Datasets:
Formats:
parquet
Languages:
English
Size:
10M - 100M
Tags:
biology
chemistry
drug-discovery
clinical-trials
protein-protein-interaction
gene-essentiality
License:
| {"question_id": "CTL4-0000", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Sacituzumab Govitecan-hziy\nDrug type: antibody_drug_conjugate\nCondition: Metastatic Triple Negative Breast Cancer\nTherapeutic area: oncology", "metadata": {"intervention_id": 4477, "condition_id": 7312, "intervention_name": "Sacituzumab Govitecan-hziy", "condition_name": "Metastatic Triple Negative Breast Cancer", "molecular_type": "antibody_drug_conjugate", "therapeutic_area": "oncology", "earliest_year": 2023}, "untested_type": null, "split": "fewshot"} | |
| {"question_id": "CTL4-0001", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Ceftaroline fosamil\nDrug type: small_molecule\nCondition: Complicated Skin and Soft Tissue Infection\nTherapeutic area: other", "metadata": {"intervention_id": 14152, "condition_id": 33442, "intervention_name": "Ceftaroline fosamil", "condition_name": "Complicated Skin and Soft Tissue Infection", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2015}, "untested_type": null, "split": "fewshot"} | |
| {"question_id": "CTL4-0002", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Travoprost/brinzolamide\nCondition: Glaucoma\nTherapeutic area: other", "metadata": {"intervention_id": 138745, "condition_id": 597, "intervention_name": "Travoprost/brinzolamide", "condition_name": "Glaucoma", "molecular_type": null, "therapeutic_area": "other", "earliest_year": 2009}, "untested_type": null, "split": "fewshot"} | |
| {"question_id": "CTL4-0003", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: fludarabine phosphate\nDrug type: small_molecule\nCondition: Stage IV Adult T-cell Leukemia/Lymphoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 743, "condition_id": 2150, "intervention_name": "fludarabine phosphate", "condition_name": "Stage IV Adult T-cell Leukemia/Lymphoma", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2017}, "untested_type": null, "split": "fewshot"} | |
| {"question_id": "CTL4-0004", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Omecamtiv Mecarbil Swellable Core Technology F2\nCondition: Modified Release Oral Formulation\nTherapeutic area: other", "metadata": {"intervention_id": 49184, "condition_id": 15116, "intervention_name": "Omecamtiv Mecarbil Swellable Core Technology F2", "condition_name": "Modified Release Oral Formulation", "molecular_type": null, "therapeutic_area": "other", "earliest_year": 2015}, "untested_type": null, "split": "fewshot"} | |
| {"question_id": "CTL4-0005", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: L - Asparginase\nCondition: Acute Myeloid Leukemia\nTherapeutic area: oncology", "metadata": {"intervention_id": 161745, "condition_id": 54, "intervention_name": "L - Asparginase", "condition_name": "Acute Myeloid Leukemia", "molecular_type": null, "therapeutic_area": "oncology", "earliest_year": 2023}, "untested_type": null, "split": "fewshot"} | |
| {"question_id": "CTL4-0006", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: dupliumab\nDrug type: monoclonal_antibody\nCondition: Food Allergy\nTherapeutic area: other", "metadata": {"intervention_id": 114242, "condition_id": 4002, "intervention_name": "dupliumab", "condition_name": "Food Allergy", "molecular_type": "monoclonal_antibody", "therapeutic_area": "other", "earliest_year": 2024}, "untested_type": null, "split": "fewshot"} | |
| {"question_id": "CTL4-0007", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: INCB 99280 with Ipilimumab\nCondition: Microsatellite Instability - High (MSI-H)\nTherapeutic area: other", "metadata": {"intervention_id": 10691, "condition_id": 46232, "intervention_name": "INCB 99280 with Ipilimumab", "condition_name": "Microsatellite Instability - High (MSI-H)", "molecular_type": null, "therapeutic_area": "other", "earliest_year": 2024}, "untested_type": null, "split": "fewshot"} | |
| {"question_id": "CTL4-0008", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: bupropion hydrochloride\nDrug type: small_molecule\nCondition: Smoking Cessation\nTherapeutic area: other", "metadata": {"intervention_id": 31120, "condition_id": 1229, "intervention_name": "bupropion hydrochloride", "condition_name": "Smoking Cessation", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2015}, "untested_type": null, "split": "fewshot"} | |
| {"question_id": "CTL4-0009", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Ropivacaine 0.2%\nDrug type: small_molecule\nCondition: Hallux Valgus\nTherapeutic area: other", "metadata": {"intervention_id": 6160, "condition_id": 3650, "intervention_name": "Ropivacaine 0.2%", "condition_name": "Hallux Valgus", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2017}, "untested_type": null, "split": "fewshot"} | |
| {"question_id": "CTL4-0010", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: CpG-STAT3 siRNA CAS3/SS3\nCondition: Recurrent B-Cell Non-Hodgkin Lymphoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 97112, "condition_id": 7347, "intervention_name": "CpG-STAT3 siRNA CAS3/SS3", "condition_name": "Recurrent B-Cell Non-Hodgkin Lymphoma", "molecular_type": null, "therapeutic_area": "oncology", "earliest_year": 2024}, "untested_type": null, "split": "fewshot"} | |
| {"question_id": "CTL4-0011", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: vincristine sulfate\nDrug type: small_molecule\nCondition: Ann Arbor Stage IV Adult Lymphoblastic Lymphoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 1413, "condition_id": 45389, "intervention_name": "vincristine sulfate", "condition_name": "Ann Arbor Stage IV Adult Lymphoblastic Lymphoma", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2026}, "untested_type": null, "split": "fewshot"} | |
| {"question_id": "CTL4-0012", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Sesderma LACTYFERRIN™ Forte and Sesderma ZINC Defense™\nCondition: COVID-19\nTherapeutic area: infectious", "metadata": {"intervention_id": 35906, "condition_id": 97, "intervention_name": "Sesderma LACTYFERRIN™ Forte and Sesderma ZINC Defense™", "condition_name": "COVID-19", "molecular_type": null, "therapeutic_area": "infectious", "earliest_year": 2024}, "untested_type": null, "split": "fewshot"} | |
| {"question_id": "CTL4-0013", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Panitumumab\nDrug type: monoclonal_antibody\nCondition: Stage IIIB Colorectal Cancer AJCC v8\nTherapeutic area: oncology", "metadata": {"intervention_id": 374, "condition_id": 16459, "intervention_name": "Panitumumab", "condition_name": "Stage IIIB Colorectal Cancer AJCC v8", "molecular_type": "monoclonal_antibody", "therapeutic_area": "oncology", "earliest_year": 2024}, "untested_type": null, "split": "fewshot"} | |
| {"question_id": "CTL4-0014", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: pUMVC3-hIGFBP-2 Multi-Epitope Plasmid DNA Vaccine\nCondition: Stage III Fallopian Tube Cancer\nTherapeutic area: oncology", "metadata": {"intervention_id": 56037, "condition_id": 23111, "intervention_name": "pUMVC3-hIGFBP-2 Multi-Epitope Plasmid DNA Vaccine", "condition_name": "Stage III Fallopian Tube Cancer", "molecular_type": null, "therapeutic_area": "oncology", "earliest_year": 2019}, "untested_type": null, "split": "fewshot"} | |
| {"question_id": "CTL4-0015", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Spartalizumab\nDrug type: monoclonal_antibody\nCondition: Esophageal SCC\nTherapeutic area: other", "metadata": {"intervention_id": 6907, "condition_id": 15533, "intervention_name": "Spartalizumab", "condition_name": "Esophageal SCC", "molecular_type": "monoclonal_antibody", "therapeutic_area": "other", "earliest_year": 2024}, "untested_type": null, "split": "fewshot"} | |
| {"question_id": "CTL4-0016", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Lenalidomide\nDrug type: small_molecule\nCondition: Refractory Splenic Marginal Zone Lymphoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 616, "condition_id": 20970, "intervention_name": "Lenalidomide", "condition_name": "Refractory Splenic Marginal Zone Lymphoma", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2024}, "untested_type": null, "split": "fewshot"} | |
| {"question_id": "CTL4-0017", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Saxagliptin\nDrug type: small_molecule\nCondition: Diabetes Mellitus, Type 2\nTherapeutic area: metabolic", "metadata": {"intervention_id": 1752, "condition_id": 446, "intervention_name": "Saxagliptin", "condition_name": "Diabetes Mellitus, Type 2", "molecular_type": "small_molecule", "therapeutic_area": "metabolic", "earliest_year": 2010}, "untested_type": null, "split": "fewshot"} | |
| {"question_id": "CTL4-0018", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Selumetinib\nDrug type: small_molecule\nCondition: Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7\nTherapeutic area: oncology", "metadata": {"intervention_id": 386, "condition_id": 6964, "intervention_name": "Selumetinib", "condition_name": "Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2023}, "untested_type": null, "split": "fewshot"} | |
| {"question_id": "CTL4-0019", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: leucovorin calcium\nDrug type: small_molecule\nCondition: Liver Metastases\nTherapeutic area: other", "metadata": {"intervention_id": 1196, "condition_id": 2709, "intervention_name": "leucovorin calcium", "condition_name": "Liver Metastases", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2014}, "untested_type": null, "split": "fewshot"} | |
| {"question_id": "CTL4-0020", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Cyclophosphamide\nDrug type: small_molecule\nCondition: Stem Cell Transplantation\nTherapeutic area: other", "metadata": {"intervention_id": 31, "condition_id": 53, "intervention_name": "Cyclophosphamide", "condition_name": "Stem Cell Transplantation", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2023}, "untested_type": null, "split": "fewshot"} | |
| {"question_id": "CTL4-0021", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: dabigatran etexilate\nDrug type: small_molecule\nCondition: Stroke\nTherapeutic area: neurology", "metadata": {"intervention_id": 951, "condition_id": 274, "intervention_name": "dabigatran etexilate", "condition_name": "Stroke", "molecular_type": "small_molecule", "therapeutic_area": "neurology", "earliest_year": 2018}, "untested_type": null, "split": "fewshot"} | |
| {"question_id": "CTL4-0022", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: filgrastim\nDrug type: peptide\nCondition: Diamond-Blackfan Anemia\nTherapeutic area: other", "metadata": {"intervention_id": 233, "condition_id": 3998, "intervention_name": "filgrastim", "condition_name": "Diamond-Blackfan Anemia", "molecular_type": "peptide", "therapeutic_area": "other", "earliest_year": 2007}, "untested_type": null, "split": "fewshot"} | |
| {"question_id": "CTL4-0023", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: methylprednisolone\nDrug type: small_molecule\nCondition: Malignant Lymphoma, Non-Hodgkin\nTherapeutic area: oncology", "metadata": {"intervention_id": 18, "condition_id": 32446, "intervention_name": "methylprednisolone", "condition_name": "Malignant Lymphoma, Non-Hodgkin", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2010}, "untested_type": null, "split": "fewshot"} | |
| {"question_id": "CTL4-0024", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Veltassa Oral Powder Product\nCondition: Hyperkalemia\nTherapeutic area: other", "metadata": {"intervention_id": 44609, "condition_id": 7039, "intervention_name": "Veltassa Oral Powder Product", "condition_name": "Hyperkalemia", "molecular_type": null, "therapeutic_area": "other", "earliest_year": 2024}, "untested_type": null, "split": "fewshot"} | |
| {"question_id": "CTL4-0025", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: escitalopram\nDrug type: small_molecule\nCondition: Opiate Dependence\nTherapeutic area: other", "metadata": {"intervention_id": 1252, "condition_id": 5739, "intervention_name": "escitalopram", "condition_name": "Opiate Dependence", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2009}, "untested_type": null, "split": "val"} | |
| {"question_id": "CTL4-0026", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Morphine\nDrug type: small_molecule\nCondition: Sickle Cell Crisis\nTherapeutic area: other", "metadata": {"intervention_id": 668, "condition_id": 12225, "intervention_name": "Morphine", "condition_name": "Sickle Cell Crisis", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2016}, "untested_type": null, "split": "val"} | |
| {"question_id": "CTL4-0027", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Gabapentin\nDrug type: small_molecule\nCondition: Burn Injury\nTherapeutic area: other", "metadata": {"intervention_id": 2473, "condition_id": 11930, "intervention_name": "Gabapentin", "condition_name": "Burn Injury", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2011}, "untested_type": null, "split": "val"} | |
| {"question_id": "CTL4-0028", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Prevenar\nDrug type: other_biologic\nCondition: Influenza\nTherapeutic area: infectious", "metadata": {"intervention_id": 2539, "condition_id": 300, "intervention_name": "Prevenar", "condition_name": "Influenza", "molecular_type": "other_biologic", "therapeutic_area": "infectious", "earliest_year": 2010}, "untested_type": null, "split": "val"} | |
| {"question_id": "CTL4-0029", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Apremilast tablet 20 mg\nCondition: Ankylosing Spondyloarthritis\nTherapeutic area: other", "metadata": {"intervention_id": 141977, "condition_id": 41394, "intervention_name": "Apremilast tablet 20 mg", "condition_name": "Ankylosing Spondyloarthritis", "molecular_type": null, "therapeutic_area": "other", "earliest_year": 2018}, "untested_type": null, "split": "val"} | |
| {"question_id": "CTL4-0030", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Cyclophosphamide + Fludarabine Lymphodepletive Conditioning\nCondition: Diffuse Intrinsic Pontine Glioma (DIPG)\nTherapeutic area: oncology", "metadata": {"intervention_id": 147465, "condition_id": 24172, "intervention_name": "Cyclophosphamide + Fludarabine Lymphodepletive Conditioning", "condition_name": "Diffuse Intrinsic Pontine Glioma (DIPG)", "molecular_type": null, "therapeutic_area": "oncology", "earliest_year": 2025}, "untested_type": null, "split": "val"} | |
| {"question_id": "CTL4-0031", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: split dose insulin glargine\nCondition: Type 1 Diabetes\nTherapeutic area: metabolic", "metadata": {"intervention_id": 79164, "condition_id": 150, "intervention_name": "split dose insulin glargine", "condition_name": "Type 1 Diabetes", "molecular_type": null, "therapeutic_area": "metabolic", "earliest_year": 2010}, "untested_type": null, "split": "val"} | |
| {"question_id": "CTL4-0032", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Olaparib 300mg tablets\nCondition: Partial Response\nTherapeutic area: other", "metadata": {"intervention_id": 63608, "condition_id": 29039, "intervention_name": "Olaparib 300mg tablets", "condition_name": "Partial Response", "molecular_type": null, "therapeutic_area": "other", "earliest_year": 2028}, "untested_type": null, "split": "val"} | |
| {"question_id": "CTL4-0033", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Ramucirumab\nDrug type: monoclonal_antibody\nCondition: Metastatic Unresectable Gastric Adenocarcinoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 5720, "condition_id": 15048, "intervention_name": "Ramucirumab", "condition_name": "Metastatic Unresectable Gastric Adenocarcinoma", "molecular_type": "monoclonal_antibody", "therapeutic_area": "oncology", "earliest_year": 2023}, "untested_type": null, "split": "val"} | |
| {"question_id": "CTL4-0034", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: TG02-treatment\nCondition: Rectal Cancer\nTherapeutic area: oncology", "metadata": {"intervention_id": 88113, "condition_id": 1127, "intervention_name": "TG02-treatment", "condition_name": "Rectal Cancer", "molecular_type": null, "therapeutic_area": "oncology", "earliest_year": 2019}, "untested_type": null, "split": "val"} | |
| {"question_id": "CTL4-0035", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Dexamethasone\nDrug type: small_molecule\nCondition: Mastectomy\nTherapeutic area: other", "metadata": {"intervention_id": 21, "condition_id": 13513, "intervention_name": "Dexamethasone", "condition_name": "Mastectomy", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2018}, "untested_type": null, "split": "val"} | |
| {"question_id": "CTL4-0036", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Paclitaxel\nDrug type: small_molecule\nCondition: Fallopian Tube Cancer\nTherapeutic area: oncology", "metadata": {"intervention_id": 32, "condition_id": 576, "intervention_name": "Paclitaxel", "condition_name": "Fallopian Tube Cancer", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2008}, "untested_type": null, "split": "val"} | |
| {"question_id": "CTL4-0037", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Carboplatin/ Paclitaxel\nCondition: Non-Small Cell Lung Cancer\nTherapeutic area: oncology", "metadata": {"intervention_id": 98972, "condition_id": 108, "intervention_name": "Carboplatin/ Paclitaxel", "condition_name": "Non-Small Cell Lung Cancer", "molecular_type": null, "therapeutic_area": "oncology", "earliest_year": 2025}, "untested_type": null, "split": "val"} | |
| {"question_id": "CTL4-0038", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Atezolizumab\nDrug type: monoclonal_antibody\nCondition: Renal Cancer\nTherapeutic area: oncology", "metadata": {"intervention_id": 1333, "condition_id": 1801, "intervention_name": "Atezolizumab", "condition_name": "Renal Cancer", "molecular_type": "monoclonal_antibody", "therapeutic_area": "oncology", "earliest_year": 2024}, "untested_type": null, "split": "val"} | |
| {"question_id": "CTL4-0039", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: octreotide acetate\nDrug type: peptide\nCondition: Gastric Neuroendocrine Tumor G1\nTherapeutic area: oncology", "metadata": {"intervention_id": 20086, "condition_id": 39020, "intervention_name": "octreotide acetate", "condition_name": "Gastric Neuroendocrine Tumor G1", "molecular_type": "peptide", "therapeutic_area": "oncology", "earliest_year": 2027}, "untested_type": null, "split": "val"} | |
| {"question_id": "CTL4-0040", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: graft-versus-tumor induction therapy\nCondition: Leukemia\nTherapeutic area: oncology", "metadata": {"intervention_id": 740, "condition_id": 25, "intervention_name": "graft-versus-tumor induction therapy", "condition_name": "Leukemia", "molecular_type": null, "therapeutic_area": "oncology", "earliest_year": 2012}, "untested_type": null, "split": "val"} | |
| {"question_id": "CTL4-0041", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Cyclosporine\nDrug type: peptide\nCondition: Heart Diseases\nTherapeutic area: cardiology", "metadata": {"intervention_id": 3038, "condition_id": 954, "intervention_name": "Cyclosporine", "condition_name": "Heart Diseases", "molecular_type": "peptide", "therapeutic_area": "cardiology", "earliest_year": 2008}, "untested_type": null, "split": "val"} | |
| {"question_id": "CTL4-0042", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: TSO\nDrug type: small_molecule\nCondition: Autistic Spectrum Disorders\nTherapeutic area: other", "metadata": {"intervention_id": 159225, "condition_id": 49072, "intervention_name": "TSO", "condition_name": "Autistic Spectrum Disorders", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2015}, "untested_type": null, "split": "val"} | |
| {"question_id": "CTL4-0043", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Subcutaneous (SC) SEA-CD40\nCondition: Lymphoma, Follicular\nTherapeutic area: oncology", "metadata": {"intervention_id": 118841, "condition_id": 4667, "intervention_name": "Subcutaneous (SC) SEA-CD40", "condition_name": "Lymphoma, Follicular", "molecular_type": null, "therapeutic_area": "oncology", "earliest_year": 2023}, "untested_type": null, "split": "val"} | |
| {"question_id": "CTL4-0044", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Atezolizumab\nDrug type: monoclonal_antibody\nCondition: Extensive-Stage Small Cell Lung Cancer\nTherapeutic area: oncology", "metadata": {"intervention_id": 1333, "condition_id": 4731, "intervention_name": "Atezolizumab", "condition_name": "Extensive-Stage Small Cell Lung Cancer", "molecular_type": "monoclonal_antibody", "therapeutic_area": "oncology", "earliest_year": 2024}, "untested_type": null, "split": "val"} | |
| {"question_id": "CTL4-0045", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Cyclophosphamide\nDrug type: small_molecule\nCondition: Lupus Nephritis\nTherapeutic area: autoimmune", "metadata": {"intervention_id": 31, "condition_id": 213, "intervention_name": "Cyclophosphamide", "condition_name": "Lupus Nephritis", "molecular_type": "small_molecule", "therapeutic_area": "autoimmune", "earliest_year": 2010}, "untested_type": null, "split": "val"} | |
| {"question_id": "CTL4-0046", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Acetaminophen\nDrug type: small_molecule\nCondition: Carpometacarpal Osteoarthritis\nTherapeutic area: other", "metadata": {"intervention_id": 103, "condition_id": 36512, "intervention_name": "Acetaminophen", "condition_name": "Carpometacarpal Osteoarthritis", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2024}, "untested_type": null, "split": "val"} | |
| {"question_id": "CTL4-0047", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: immunosuppressive therapy\nCondition: Stage I Chronic Lymphocytic Leukemia\nTherapeutic area: oncology", "metadata": {"intervention_id": 4159, "condition_id": 5684, "intervention_name": "immunosuppressive therapy", "condition_name": "Stage I Chronic Lymphocytic Leukemia", "molecular_type": null, "therapeutic_area": "oncology", "earliest_year": 2017}, "untested_type": null, "split": "val"} | |
| {"question_id": "CTL4-0048", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Nivolumab\nDrug type: monoclonal_antibody\nCondition: Prognostic Stage IIIB Breast Cancer AJCC v8\nTherapeutic area: oncology", "metadata": {"intervention_id": 581, "condition_id": 4149, "intervention_name": "Nivolumab", "condition_name": "Prognostic Stage IIIB Breast Cancer AJCC v8", "molecular_type": "monoclonal_antibody", "therapeutic_area": "oncology", "earliest_year": 2023}, "untested_type": null, "split": "val"} | |
| {"question_id": "CTL4-0049", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Melphalan\nDrug type: small_molecule\nCondition: Myeloma\nTherapeutic area: oncology", "metadata": {"intervention_id": 1070, "condition_id": 52, "intervention_name": "Melphalan", "condition_name": "Myeloma", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2011}, "untested_type": null, "split": "val"} | |
| {"question_id": "CTL4-0050", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: FOLFOXIRI\nCondition: Metastatic Colorectal Cancer\nTherapeutic area: oncology", "metadata": {"intervention_id": 4910, "condition_id": 37, "intervention_name": "FOLFOXIRI", "condition_name": "Metastatic Colorectal Cancer", "molecular_type": null, "therapeutic_area": "oncology", "earliest_year": 2024}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0051", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Trimodulin\nDrug type: small_molecule\nCondition: Viral Pneumonia\nTherapeutic area: other", "metadata": {"intervention_id": 78164, "condition_id": 11364, "intervention_name": "Trimodulin", "condition_name": "Viral Pneumonia", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2025}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0052", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: BOTOX-A\nDrug type: peptide\nCondition: Refractory Medical Treatment After Rectal Resection\nTherapeutic area: other", "metadata": {"intervention_id": 31639, "condition_id": 2162, "intervention_name": "BOTOX-A", "condition_name": "Refractory Medical Treatment After Rectal Resection", "molecular_type": "peptide", "therapeutic_area": "other", "earliest_year": 2023}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0053", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Oral sodium chloride\nDrug type: small_molecule\nCondition: Heart Failure\nTherapeutic area: cardiology", "metadata": {"intervention_id": 100790, "condition_id": 5, "intervention_name": "Oral sodium chloride", "condition_name": "Heart Failure", "molecular_type": "small_molecule", "therapeutic_area": "cardiology", "earliest_year": 2019}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0054", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Cyclophosphamide\nDrug type: small_molecule\nCondition: Stage IV Breast Cancer AJCC v6 and v7\nTherapeutic area: oncology", "metadata": {"intervention_id": 31, "condition_id": 5465, "intervention_name": "Cyclophosphamide", "condition_name": "Stage IV Breast Cancer AJCC v6 and v7", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2025}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0055", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Fesoterodine\nDrug type: small_molecule\nCondition: Nocturia\nTherapeutic area: other", "metadata": {"intervention_id": 7750, "condition_id": 203, "intervention_name": "Fesoterodine", "condition_name": "Nocturia", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2016}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0056", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: AZD0466\nDrug type: monoclonal_antibody\nCondition: Non-Hodgkin Lymphoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 3717, "condition_id": 973, "intervention_name": "AZD0466", "condition_name": "Non-Hodgkin Lymphoma", "molecular_type": "monoclonal_antibody", "therapeutic_area": "oncology", "earliest_year": 2023}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0057", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Rozibafusp Alfa\nDrug type: peptide\nCondition: Systemic Lupus Erythematosus (SLE)\nTherapeutic area: autoimmune", "metadata": {"intervention_id": 45501, "condition_id": 1219, "intervention_name": "Rozibafusp Alfa", "condition_name": "Systemic Lupus Erythematosus (SLE)", "molecular_type": "peptide", "therapeutic_area": "autoimmune", "earliest_year": 2023}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0058", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: gemcitabine hydrochloride\nDrug type: small_molecule\nCondition: Stage 0is Renal Pelvis and Ureter Cancer AJCC v8\nTherapeutic area: oncology", "metadata": {"intervention_id": 993, "condition_id": 3680, "intervention_name": "gemcitabine hydrochloride", "condition_name": "Stage 0is Renal Pelvis and Ureter Cancer AJCC v8", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2023}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0059", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Prednisone\nDrug type: small_molecule\nCondition: Sudden Sensorineural Hearing Loss (SSNHL)\nTherapeutic area: other", "metadata": {"intervention_id": 165, "condition_id": 26944, "intervention_name": "Prednisone", "condition_name": "Sudden Sensorineural Hearing Loss (SSNHL)", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2023}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0060", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Regorafenib\nDrug type: small_molecule\nCondition: Hepatocellular Carcinoma (HCC)\nTherapeutic area: oncology", "metadata": {"intervention_id": 418, "condition_id": 498, "intervention_name": "Regorafenib", "condition_name": "Hepatocellular Carcinoma (HCC)", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2025}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0061", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Nanrilkefusp Alfa\nDrug type: peptide\nCondition: Castration-resistant Prostate Cancer\nTherapeutic area: oncology", "metadata": {"intervention_id": 61110, "condition_id": 3743, "intervention_name": "Nanrilkefusp Alfa", "condition_name": "Castration-resistant Prostate Cancer", "molecular_type": "peptide", "therapeutic_area": "oncology", "earliest_year": 2024}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0062", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Relebactam 250 mg\nCondition: Pyelonephritis\nTherapeutic area: other", "metadata": {"intervention_id": 110873, "condition_id": 6520, "intervention_name": "Relebactam 250 mg", "condition_name": "Pyelonephritis", "molecular_type": null, "therapeutic_area": "other", "earliest_year": 2015}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0063", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Oral Aprepitant\nCondition: Chemotherapy\nTherapeutic area: other", "metadata": {"intervention_id": 115311, "condition_id": 568, "intervention_name": "Oral Aprepitant", "condition_name": "Chemotherapy", "molecular_type": null, "therapeutic_area": "other", "earliest_year": 2016}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0064", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Bevacizumab\nDrug type: monoclonal_antibody\nCondition: Stage IVA Major Salivary Gland Cancer AJCC v7\nTherapeutic area: oncology", "metadata": {"intervention_id": 28, "condition_id": 20213, "intervention_name": "Bevacizumab", "condition_name": "Stage IVA Major Salivary Gland Cancer AJCC v7", "molecular_type": "monoclonal_antibody", "therapeutic_area": "oncology", "earliest_year": 2026}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0065", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Paclitaxel injection\nDrug type: small_molecule\nCondition: Sarcoma of Uterus\nTherapeutic area: oncology", "metadata": {"intervention_id": 5865, "condition_id": 44159, "intervention_name": "Paclitaxel injection", "condition_name": "Sarcoma of Uterus", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2025}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0066", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Local standard of Care\nCondition: Hyperkalaemia\nTherapeutic area: other", "metadata": {"intervention_id": 45080, "condition_id": 15406, "intervention_name": "Local standard of Care", "condition_name": "Hyperkalaemia", "molecular_type": null, "therapeutic_area": "other", "earliest_year": 2024}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0067", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Thiotepa\nDrug type: small_molecule\nCondition: Solid Tumor\nTherapeutic area: oncology", "metadata": {"intervention_id": 1071, "condition_id": 345, "intervention_name": "Thiotepa", "condition_name": "Solid Tumor", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2017}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0068", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Docetaxel\nDrug type: small_molecule\nCondition: Stage IIIC Lung Cancer AJCC v8\nTherapeutic area: oncology", "metadata": {"intervention_id": 729, "condition_id": 12451, "intervention_name": "Docetaxel", "condition_name": "Stage IIIC Lung Cancer AJCC v8", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2023}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0069", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Tacrolimus\nDrug type: small_molecule\nCondition: Recurrent Malignant Solid Neoplasm\nTherapeutic area: oncology", "metadata": {"intervention_id": 56, "condition_id": 5343, "intervention_name": "Tacrolimus", "condition_name": "Recurrent Malignant Solid Neoplasm", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2024}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0070", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Fenretinide/LXS Oral Powder\nCondition: Neuroblastoma\nTherapeutic area: other", "metadata": {"intervention_id": 106602, "condition_id": 199, "intervention_name": "Fenretinide/LXS Oral Powder", "condition_name": "Neuroblastoma", "molecular_type": null, "therapeutic_area": "other", "earliest_year": 2018}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0071", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Angiotensin II\nDrug type: peptide\nCondition: Kidney Failure, Acute\nTherapeutic area: other", "metadata": {"intervention_id": 9394, "condition_id": 2899, "intervention_name": "Angiotensin II", "condition_name": "Kidney Failure, Acute", "molecular_type": "peptide", "therapeutic_area": "other", "earliest_year": 2023}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0072", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Nitric Oxide\nDrug type: small_molecule\nCondition: Inflammation\nTherapeutic area: other", "metadata": {"intervention_id": 5321, "condition_id": 440, "intervention_name": "Nitric Oxide", "condition_name": "Inflammation", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2019}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0073", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Sotatercept\nDrug type: peptide\nCondition: Chemotherapy Induced Anemia\nTherapeutic area: other", "metadata": {"intervention_id": 3047, "condition_id": 5129, "intervention_name": "Sotatercept", "condition_name": "Chemotherapy Induced Anemia", "molecular_type": "peptide", "therapeutic_area": "other", "earliest_year": 2010}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0074", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Pembrolizumab\nDrug type: monoclonal_antibody\nCondition: Metastatic Solid Tumors\nTherapeutic area: oncology", "metadata": {"intervention_id": 122, "condition_id": 656, "intervention_name": "Pembrolizumab", "condition_name": "Metastatic Solid Tumors", "molecular_type": "monoclonal_antibody", "therapeutic_area": "oncology", "earliest_year": 2024}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0075", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Rapid pleurodesis protocol\nCondition: Pleural Effusion, Malignant\nTherapeutic area: other", "metadata": {"intervention_id": 164256, "condition_id": 11453, "intervention_name": "Rapid pleurodesis protocol", "condition_name": "Pleural Effusion, Malignant", "molecular_type": null, "therapeutic_area": "other", "earliest_year": 2019}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0076", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Sotatercept 30 mg\nCondition: Carcinoma, Non-Small-Cell Lung\nTherapeutic area: oncology", "metadata": {"intervention_id": 42549, "condition_id": 758, "intervention_name": "Sotatercept 30 mg", "condition_name": "Carcinoma, Non-Small-Cell Lung", "molecular_type": null, "therapeutic_area": "oncology", "earliest_year": 2012}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0077", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Enfortumab vedotin\nDrug type: antibody_drug_conjugate\nCondition: Urinary Bladder Neoplasms\nTherapeutic area: oncology", "metadata": {"intervention_id": 2258, "condition_id": 5602, "intervention_name": "Enfortumab vedotin", "condition_name": "Urinary Bladder Neoplasms", "molecular_type": "antibody_drug_conjugate", "therapeutic_area": "oncology", "earliest_year": 2025}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0078", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Benadryl®\nDrug type: small_molecule\nCondition: Nausea\nTherapeutic area: other", "metadata": {"intervention_id": 44998, "condition_id": 126, "intervention_name": "Benadryl®", "condition_name": "Nausea", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2009}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0079", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: aprepitant\nDrug type: small_molecule\nCondition: Nausea\nTherapeutic area: other", "metadata": {"intervention_id": 1259, "condition_id": 126, "intervention_name": "aprepitant", "condition_name": "Nausea", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2013}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0080", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: baltaleucel-T\nDrug type: cell_therapy\nCondition: EBV\nTherapeutic area: other", "metadata": {"intervention_id": 29604, "condition_id": 7416, "intervention_name": "baltaleucel-T", "condition_name": "EBV", "molecular_type": "cell_therapy", "therapeutic_area": "other", "earliest_year": 2018}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0081", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Lamotrigine\nDrug type: small_molecule\nCondition: Epilepsy, Partial\nTherapeutic area: neurology", "metadata": {"intervention_id": 2644, "condition_id": 3486, "intervention_name": "Lamotrigine", "condition_name": "Epilepsy, Partial", "molecular_type": "small_molecule", "therapeutic_area": "neurology", "earliest_year": 2010}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0082", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Vincristine Liposomal\nCondition: Refractory B Acute Lymphoblastic Leukemia\nTherapeutic area: oncology", "metadata": {"intervention_id": 13574, "condition_id": 4638, "intervention_name": "Vincristine Liposomal", "condition_name": "Refractory B Acute Lymphoblastic Leukemia", "molecular_type": null, "therapeutic_area": "oncology", "earliest_year": 2028}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0083", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Rimiducid\nDrug type: small_molecule\nCondition: Neoplasms by Site\nTherapeutic area: oncology", "metadata": {"intervention_id": 1982, "condition_id": 4348, "intervention_name": "Rimiducid", "condition_name": "Neoplasms by Site", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2024}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0084", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: difelikefalin 0.5 mg\nCondition: Pruritus\nTherapeutic area: other", "metadata": {"intervention_id": 28690, "condition_id": 22, "intervention_name": "difelikefalin 0.5 mg", "condition_name": "Pruritus", "molecular_type": null, "therapeutic_area": "other", "earliest_year": 2024}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0085", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: tranexamic acid\nDrug type: small_molecule\nCondition: Blood Loss\nTherapeutic area: other", "metadata": {"intervention_id": 447, "condition_id": 1161, "intervention_name": "tranexamic acid", "condition_name": "Blood Loss", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2015}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0086", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Dapagliflozin\nDrug type: small_molecule\nCondition: Immunoglobulin A Nephropathy\nTherapeutic area: other", "metadata": {"intervention_id": 394, "condition_id": 5082, "intervention_name": "Dapagliflozin", "condition_name": "Immunoglobulin A Nephropathy", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2026}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0087", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Physician's Choice of Salvage Therapy - carboplatin\nCondition: Brain Cancer\nTherapeutic area: oncology", "metadata": {"intervention_id": 82832, "condition_id": 1331, "intervention_name": "Physician's Choice of Salvage Therapy - carboplatin", "condition_name": "Brain Cancer", "molecular_type": null, "therapeutic_area": "oncology", "earliest_year": 2019}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0088", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: gemcitabine hydrochloride\nDrug type: small_molecule\nCondition: Stage IIIB Gallbladder Cancer AJCC v8\nTherapeutic area: oncology", "metadata": {"intervention_id": 993, "condition_id": 14774, "intervention_name": "gemcitabine hydrochloride", "condition_name": "Stage IIIB Gallbladder Cancer AJCC v8", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2024}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0089", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Futibatinib\nDrug type: small_molecule\nCondition: Advanced and Metastatic Urothelial Cancer\nTherapeutic area: oncology", "metadata": {"intervention_id": 5538, "condition_id": 48836, "intervention_name": "Futibatinib", "condition_name": "Advanced and Metastatic Urothelial Cancer", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2025}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0090", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Omeprazole\nDrug type: small_molecule\nCondition: Barrett's Esophagus\nTherapeutic area: other", "metadata": {"intervention_id": 981, "condition_id": 3471, "intervention_name": "Omeprazole", "condition_name": "Barrett's Esophagus", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2014}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0091", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: MRX34\nDrug type: small_molecule\nCondition: Lymphoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 74188, "condition_id": 26, "intervention_name": "MRX34", "condition_name": "Lymphoma", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2017}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0092", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: pUMVC3-hIGFBP-2 Multi-Epitope Plasmid DNA Vaccine\nCondition: Stage IIIA Ovarian Cancer\nTherapeutic area: oncology", "metadata": {"intervention_id": 56037, "condition_id": 3629, "intervention_name": "pUMVC3-hIGFBP-2 Multi-Epitope Plasmid DNA Vaccine", "condition_name": "Stage IIIA Ovarian Cancer", "molecular_type": null, "therapeutic_area": "oncology", "earliest_year": 2019}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0093", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Metformin, if taken before\nCondition: Diabetes Mellitus, Type 2\nTherapeutic area: metabolic", "metadata": {"intervention_id": 108734, "condition_id": 446, "intervention_name": "Metformin, if taken before", "condition_name": "Diabetes Mellitus, Type 2", "molecular_type": null, "therapeutic_area": "metabolic", "earliest_year": 2019}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0094", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: autologous dendritic cell adenovirus CCL21 vaccine\nCondition: Non-small Cell Lung Cancer (NSCLC)\nTherapeutic area: oncology", "metadata": {"intervention_id": 6308, "condition_id": 3360, "intervention_name": "autologous dendritic cell adenovirus CCL21 vaccine", "condition_name": "Non-small Cell Lung Cancer (NSCLC)", "molecular_type": null, "therapeutic_area": "oncology", "earliest_year": 2017}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0095", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Misoprostol\nDrug type: small_molecule\nCondition: Gas Bloat Syndrome\nTherapeutic area: other", "metadata": {"intervention_id": 155, "condition_id": 12680, "intervention_name": "Misoprostol", "condition_name": "Gas Bloat Syndrome", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2023}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0096", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Progestin\nDrug type: small_molecule\nCondition: Infertility\nTherapeutic area: other", "metadata": {"intervention_id": 7571, "condition_id": 104, "intervention_name": "Progestin", "condition_name": "Infertility", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2016}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0097", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Cisplatin\nDrug type: small_molecule\nCondition: Non-squamous Non-small Cell Lung Cancer Stage IIIA\nTherapeutic area: oncology", "metadata": {"intervention_id": 368, "condition_id": 28754, "intervention_name": "Cisplatin", "condition_name": "Non-squamous Non-small Cell Lung Cancer Stage IIIA", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2018}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0098", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Ixazomib\nDrug type: small_molecule\nCondition: Scleroderma With Pulmonary Involvement\nTherapeutic area: respiratory", "metadata": {"intervention_id": 8723, "condition_id": 42401, "intervention_name": "Ixazomib", "condition_name": "Scleroderma With Pulmonary Involvement", "molecular_type": "small_molecule", "therapeutic_area": "respiratory", "earliest_year": 2024}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0099", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Varenicline\nDrug type: small_molecule\nCondition: Smoking Cessation\nTherapeutic area: other", "metadata": {"intervention_id": 4345, "condition_id": 1229, "intervention_name": "Varenicline", "condition_name": "Smoking Cessation", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2009}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0100", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: IOP Lowering Medications\nCondition: Ocular Hypertension\nTherapeutic area: cardiology", "metadata": {"intervention_id": 62187, "condition_id": 169, "intervention_name": "IOP Lowering Medications", "condition_name": "Ocular Hypertension", "molecular_type": null, "therapeutic_area": "cardiology", "earliest_year": 2003}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0101", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: rituximab\nDrug type: monoclonal_antibody\nCondition: Stage IV Adult Diffuse Mixed Cell Lymphoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 400, "condition_id": 2135, "intervention_name": "rituximab", "condition_name": "Stage IV Adult Diffuse Mixed Cell Lymphoma", "molecular_type": "monoclonal_antibody", "therapeutic_area": "oncology", "earliest_year": 2012}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0102", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Carboplatin\nDrug type: small_molecule\nCondition: First Line Non-Small Cell Lung Cancer\nTherapeutic area: oncology", "metadata": {"intervention_id": 148, "condition_id": 40461, "intervention_name": "Carboplatin", "condition_name": "First Line Non-Small Cell Lung Cancer", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2024}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0103", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Carboplatin\nDrug type: small_molecule\nCondition: Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7\nTherapeutic area: oncology", "metadata": {"intervention_id": 148, "condition_id": 24399, "intervention_name": "Carboplatin", "condition_name": "Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2026}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0104", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: umeclidinium/vilanterol\nCondition: Chronic Obstructive Pulmonary Disease\nTherapeutic area: respiratory", "metadata": {"intervention_id": 5455, "condition_id": 329, "intervention_name": "umeclidinium/vilanterol", "condition_name": "Chronic Obstructive Pulmonary Disease", "molecular_type": null, "therapeutic_area": "respiratory", "earliest_year": 2016}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0105", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Inhaled Human Insulin (Exubera)\nCondition: Diabetes Mellitus, Type 2\nTherapeutic area: metabolic", "metadata": {"intervention_id": 36807, "condition_id": 446, "intervention_name": "Inhaled Human Insulin (Exubera)", "condition_name": "Diabetes Mellitus, Type 2", "molecular_type": null, "therapeutic_area": "metabolic", "earliest_year": 2007}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0106", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Cefoxitin\nDrug type: small_molecule\nCondition: Urinary Tract Infections\nTherapeutic area: other", "metadata": {"intervention_id": 56135, "condition_id": 340, "intervention_name": "Cefoxitin", "condition_name": "Urinary Tract Infections", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2017}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0107", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: D/C/F/TAF FDC\nCondition: HIV-1\nTherapeutic area: infectious", "metadata": {"intervention_id": 112307, "condition_id": 5189, "intervention_name": "D/C/F/TAF FDC", "condition_name": "HIV-1", "molecular_type": null, "therapeutic_area": "infectious", "earliest_year": 2023}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0108", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Th1/Tc1 Rapa Cell Therapy\nCondition: Myeloma-Multiple\nTherapeutic area: oncology", "metadata": {"intervention_id": 8845, "condition_id": 30998, "intervention_name": "Th1/Tc1 Rapa Cell Therapy", "condition_name": "Myeloma-Multiple", "molecular_type": null, "therapeutic_area": "oncology", "earliest_year": 2017}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0109", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: kineret\nDrug type: peptide\nCondition: Macrophage Activation Syndrome\nTherapeutic area: other", "metadata": {"intervention_id": 4433, "condition_id": 4589, "intervention_name": "kineret", "condition_name": "Macrophage Activation Syndrome", "molecular_type": "peptide", "therapeutic_area": "other", "earliest_year": 2024}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0110", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Dacarbazine\nDrug type: small_molecule\nCondition: Stage III Uveal Melanoma AJCC V7\nTherapeutic area: oncology", "metadata": {"intervention_id": 118, "condition_id": 39131, "intervention_name": "Dacarbazine", "condition_name": "Stage III Uveal Melanoma AJCC V7", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2019}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0111", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: oral cannabinoid\nCondition: Photorefractive Keratectomy\nTherapeutic area: other", "metadata": {"intervention_id": 12193, "condition_id": 7018, "intervention_name": "oral cannabinoid", "condition_name": "Photorefractive Keratectomy", "molecular_type": null, "therapeutic_area": "other", "earliest_year": 2025}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0112", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Amlodipine\nDrug type: small_molecule\nCondition: Primary Aldosteronism\nTherapeutic area: other", "metadata": {"intervention_id": 1451, "condition_id": 13217, "intervention_name": "Amlodipine", "condition_name": "Primary Aldosteronism", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2023}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0113", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Mesna\nDrug type: small_molecule\nCondition: T-lymphoblastic Lymphoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 2415, "condition_id": 21405, "intervention_name": "Mesna", "condition_name": "T-lymphoblastic Lymphoma", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2024}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0114", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Amivantamab\nDrug type: monoclonal_antibody\nCondition: Non Small Cell Lung Cancer\nTherapeutic area: oncology", "metadata": {"intervention_id": 9401, "condition_id": 798, "intervention_name": "Amivantamab", "condition_name": "Non Small Cell Lung Cancer", "molecular_type": "monoclonal_antibody", "therapeutic_area": "oncology", "earliest_year": 2023}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0115", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: thalidomide\nDrug type: small_molecule\nCondition: Lung Cancer\nTherapeutic area: oncology", "metadata": {"intervention_id": 152, "condition_id": 85, "intervention_name": "thalidomide", "condition_name": "Lung Cancer", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2008}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0116", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Prednisone 5 mg\nDrug type: small_molecule\nCondition: Rhinitis\nTherapeutic area: other", "metadata": {"intervention_id": 35115, "condition_id": 1742, "intervention_name": "Prednisone 5 mg", "condition_name": "Rhinitis", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2009}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0117", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: ziprazidone\nDrug type: small_molecule\nCondition: Schizophrenia\nTherapeutic area: psychiatry", "metadata": {"intervention_id": 122320, "condition_id": 64, "intervention_name": "ziprazidone", "condition_name": "Schizophrenia", "molecular_type": "small_molecule", "therapeutic_area": "psychiatry", "earliest_year": 2005}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0118", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Dexamethasone\nDrug type: small_molecule\nCondition: Head and Neck Cancer\nTherapeutic area: oncology", "metadata": {"intervention_id": 21, "condition_id": 552, "intervention_name": "Dexamethasone", "condition_name": "Head and Neck Cancer", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2018}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0119", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: tiotropium inhalation\nDrug type: small_molecule\nCondition: Pulmonary Disease, Chronic Obstructive\nTherapeutic area: respiratory", "metadata": {"intervention_id": 8988, "condition_id": 58, "intervention_name": "tiotropium inhalation", "condition_name": "Pulmonary Disease, Chronic Obstructive", "molecular_type": "small_molecule", "therapeutic_area": "respiratory", "earliest_year": 2013}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0120", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: REM0046127 Low Dose\nCondition: Alzheimer Disease\nTherapeutic area: neurology", "metadata": {"intervention_id": 75640, "condition_id": 353, "intervention_name": "REM0046127 Low Dose", "condition_name": "Alzheimer Disease", "molecular_type": null, "therapeutic_area": "neurology", "earliest_year": 2024}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0121", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Doxorubicin\nDrug type: small_molecule\nCondition: Prognostic Stage IIIB Breast Cancer AJCC v8\nTherapeutic area: oncology", "metadata": {"intervention_id": 1716, "condition_id": 4149, "intervention_name": "Doxorubicin", "condition_name": "Prognostic Stage IIIB Breast Cancer AJCC v8", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2023}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0122", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Albumin (Human) 5%, USP\nCondition: Postural Orthostatic Tachycardia Syndrome\nTherapeutic area: other", "metadata": {"intervention_id": 113307, "condition_id": 7431, "intervention_name": "Albumin (Human) 5%, USP", "condition_name": "Postural Orthostatic Tachycardia Syndrome", "molecular_type": null, "therapeutic_area": "other", "earliest_year": 2024}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0123", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Durvalumab\nDrug type: monoclonal_antibody\nCondition: Germ Cell Tumor\nTherapeutic area: oncology", "metadata": {"intervention_id": 267, "condition_id": 6705, "intervention_name": "Durvalumab", "condition_name": "Germ Cell Tumor", "molecular_type": "monoclonal_antibody", "therapeutic_area": "oncology", "earliest_year": 2019}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0124", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Sotatercept 30 mg\nCondition: Bladder Cancer\nTherapeutic area: oncology", "metadata": {"intervention_id": 42549, "condition_id": 7, "intervention_name": "Sotatercept 30 mg", "condition_name": "Bladder Cancer", "molecular_type": null, "therapeutic_area": "oncology", "earliest_year": 2012}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0125", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: triptorelin\nDrug type: peptide\nCondition: Progesterone Receptor Positive Tumor\nTherapeutic area: oncology", "metadata": {"intervention_id": 6064, "condition_id": 14444, "intervention_name": "triptorelin", "condition_name": "Progesterone Receptor Positive Tumor", "molecular_type": "peptide", "therapeutic_area": "oncology", "earliest_year": 2024}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0126", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Olaparib\nDrug type: small_molecule\nCondition: Platinum-refractory Ovarian Carcinoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 894, "condition_id": 19881, "intervention_name": "Olaparib", "condition_name": "Platinum-refractory Ovarian Carcinoma", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2023}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0127", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Nalbuphine\nDrug type: small_molecule\nCondition: Pharmacokinetic\nTherapeutic area: other", "metadata": {"intervention_id": 2746, "condition_id": 1947, "intervention_name": "Nalbuphine", "condition_name": "Pharmacokinetic", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2018}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0128", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Oral N-Acetylcysteine\nCondition: Focus is Determination of the Role of SNO-Hb in Forearm Blood Flow Regulation\nTherapeutic area: other", "metadata": {"intervention_id": 27323, "condition_id": 20503, "intervention_name": "Oral N-Acetylcysteine", "condition_name": "Focus is Determination of the Role of SNO-Hb in Forearm Blood Flow Regulation", "molecular_type": null, "therapeutic_area": "other", "earliest_year": 2013}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0129", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Dalteparin\nDrug type: other_biologic\nCondition: Gonadal Thrombosis\nTherapeutic area: other", "metadata": {"intervention_id": 579, "condition_id": 17000, "intervention_name": "Dalteparin", "condition_name": "Gonadal Thrombosis", "molecular_type": "other_biologic", "therapeutic_area": "other", "earliest_year": 2019}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0130", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Trastuzumab\nDrug type: monoclonal_antibody\nCondition: Stage IIIB Breast Cancer AJCC v7\nTherapeutic area: oncology", "metadata": {"intervention_id": 209, "condition_id": 15942, "intervention_name": "Trastuzumab", "condition_name": "Stage IIIB Breast Cancer AJCC v7", "molecular_type": "monoclonal_antibody", "therapeutic_area": "oncology", "earliest_year": 2024}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0131", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Aspirin\nDrug type: small_molecule\nCondition: Platelet Function\nTherapeutic area: other", "metadata": {"intervention_id": 1441, "condition_id": 18212, "intervention_name": "Aspirin", "condition_name": "Platelet Function", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2023}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0132", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Estradiol\nDrug type: small_molecule\nCondition: Painful Intercourse\nTherapeutic area: other", "metadata": {"intervention_id": 823, "condition_id": 8961, "intervention_name": "Estradiol", "condition_name": "Painful Intercourse", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2013}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0133", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Frozen Plasma Product, Human\nCondition: Bleeding Cardiac Surgery Patients\nTherapeutic area: cardiology", "metadata": {"intervention_id": 91473, "condition_id": 21897, "intervention_name": "Frozen Plasma Product, Human", "condition_name": "Bleeding Cardiac Surgery Patients", "molecular_type": null, "therapeutic_area": "cardiology", "earliest_year": 2024}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0134", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Venetoclax\nDrug type: small_molecule\nCondition: Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm\nTherapeutic area: oncology", "metadata": {"intervention_id": 684, "condition_id": 19069, "intervention_name": "Venetoclax", "condition_name": "Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2026}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0135", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: AZD1152\nDrug type: small_molecule\nCondition: Solid Tumours\nTherapeutic area: oncology", "metadata": {"intervention_id": 20085, "condition_id": 2296, "intervention_name": "AZD1152", "condition_name": "Solid Tumours", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2007}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0136", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Tocilizumab\nDrug type: monoclonal_antibody\nCondition: Squamous Cell Cancer of Head and Neck (SCCHN)\nTherapeutic area: oncology", "metadata": {"intervention_id": 1408, "condition_id": 13522, "intervention_name": "Tocilizumab", "condition_name": "Squamous Cell Cancer of Head and Neck (SCCHN)", "molecular_type": "monoclonal_antibody", "therapeutic_area": "oncology", "earliest_year": 2025}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0137", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Yondelis\nDrug type: small_molecule\nCondition: Liposarcoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 113885, "condition_id": 1410, "intervention_name": "Yondelis", "condition_name": "Liposarcoma", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2008}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0138", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Cyclophosphamide\nDrug type: small_molecule\nCondition: Metastatic Melanoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 31, "condition_id": 220, "intervention_name": "Cyclophosphamide", "condition_name": "Metastatic Melanoma", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2011}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0139", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Denosumab\nDrug type: monoclonal_antibody\nCondition: Multiple Myeloma Bone Lesions\nTherapeutic area: oncology", "metadata": {"intervention_id": 1645, "condition_id": 51088, "intervention_name": "Denosumab", "condition_name": "Multiple Myeloma Bone Lesions", "molecular_type": "monoclonal_antibody", "therapeutic_area": "oncology", "earliest_year": 2019}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0140", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Nivolumab\nDrug type: monoclonal_antibody\nCondition: Pathologic Stage III Merkel Cell Carcinoma AJCC v8\nTherapeutic area: oncology", "metadata": {"intervention_id": 581, "condition_id": 26860, "intervention_name": "Nivolumab", "condition_name": "Pathologic Stage III Merkel Cell Carcinoma AJCC v8", "molecular_type": "monoclonal_antibody", "therapeutic_area": "oncology", "earliest_year": 2025}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0141", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Primaquine single dose over 14 days\nCondition: Malaria, Vivax\nTherapeutic area: infectious", "metadata": {"intervention_id": 79559, "condition_id": 5461, "intervention_name": "Primaquine single dose over 14 days", "condition_name": "Malaria, Vivax", "molecular_type": null, "therapeutic_area": "infectious", "earliest_year": 2023}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0142", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Dexamethasone\nDrug type: small_molecule\nCondition: Shoulder Pain\nTherapeutic area: other", "metadata": {"intervention_id": 21, "condition_id": 4044, "intervention_name": "Dexamethasone", "condition_name": "Shoulder Pain", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2026}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0143", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Dexamethasone 4mg\nDrug type: small_molecule\nCondition: Dexamethasone Effect on miRNA Profile in Healthy Humans\nTherapeutic area: other", "metadata": {"intervention_id": 1726, "condition_id": 37267, "intervention_name": "Dexamethasone 4mg", "condition_name": "Dexamethasone Effect on miRNA Profile in Healthy Humans", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2019}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0144", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Paclitaxel\nDrug type: small_molecule\nCondition: Stage IIIA Esophageal Cancer AJCC v7\nTherapeutic area: oncology", "metadata": {"intervention_id": 32, "condition_id": 38728, "intervention_name": "Paclitaxel", "condition_name": "Stage IIIA Esophageal Cancer AJCC v7", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2023}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0145", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Erenumab Prefilled Syringe\nCondition: Rhinosinusitis\nTherapeutic area: other", "metadata": {"intervention_id": 81902, "condition_id": 3020, "intervention_name": "Erenumab Prefilled Syringe", "condition_name": "Rhinosinusitis", "molecular_type": null, "therapeutic_area": "other", "earliest_year": 2023}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0146", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: filgrastim\nDrug type: peptide\nCondition: Stage I Adrenal Cortical Carcinoma AJCC v7\nTherapeutic area: oncology", "metadata": {"intervention_id": 233, "condition_id": 3293, "intervention_name": "filgrastim", "condition_name": "Stage I Adrenal Cortical Carcinoma AJCC v7", "molecular_type": "peptide", "therapeutic_area": "oncology", "earliest_year": 2023}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0147", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Ramucirumab\nDrug type: monoclonal_antibody\nCondition: Synovial Sarcoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 5720, "condition_id": 7295, "intervention_name": "Ramucirumab", "condition_name": "Synovial Sarcoma", "molecular_type": "monoclonal_antibody", "therapeutic_area": "oncology", "earliest_year": 2023}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0148", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Cyclophosphamide and Rituximab\nDrug type: small_molecule\nCondition: Recurrent Grade 3 Follicular Lymphoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 168511, "condition_id": 2053, "intervention_name": "Cyclophosphamide and Rituximab", "condition_name": "Recurrent Grade 3 Follicular Lymphoma", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2009}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0149", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Inclacumab\nDrug type: monoclonal_antibody\nCondition: Sickle Cell Disease\nTherapeutic area: other", "metadata": {"intervention_id": 86483, "condition_id": 602, "intervention_name": "Inclacumab", "condition_name": "Sickle Cell Disease", "molecular_type": "monoclonal_antibody", "therapeutic_area": "other", "earliest_year": 2023}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0150", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Dobutamine\nDrug type: small_molecule\nCondition: Shock\nTherapeutic area: other", "metadata": {"intervention_id": 16883, "condition_id": 1426, "intervention_name": "Dobutamine", "condition_name": "Shock", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2017}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0151", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: DPH 50mg\nCondition: Sleep\nTherapeutic area: other", "metadata": {"intervention_id": 128133, "condition_id": 20, "intervention_name": "DPH 50mg", "condition_name": "Sleep", "molecular_type": null, "therapeutic_area": "other", "earliest_year": 2008}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0152", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Trifluridine and Tipiracil Hydrochloride\nCondition: Stage IVA Colorectal Cancer AJCC v7\nTherapeutic area: oncology", "metadata": {"intervention_id": 902, "condition_id": 5701, "intervention_name": "Trifluridine and Tipiracil Hydrochloride", "condition_name": "Stage IVA Colorectal Cancer AJCC v7", "molecular_type": null, "therapeutic_area": "oncology", "earliest_year": 2023}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0153", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: G-CSF\nDrug type: peptide\nCondition: Infertility, Female\nTherapeutic area: other", "metadata": {"intervention_id": 1705, "condition_id": 714, "intervention_name": "G-CSF", "condition_name": "Infertility, Female", "molecular_type": "peptide", "therapeutic_area": "other", "earliest_year": 2013}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0154", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: B-701\nDrug type: monoclonal_antibody\nCondition: Bladder Cancer\nTherapeutic area: oncology", "metadata": {"intervention_id": 23808, "condition_id": 7, "intervention_name": "B-701", "condition_name": "Bladder Cancer", "molecular_type": "monoclonal_antibody", "therapeutic_area": "oncology", "earliest_year": 2017}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0155", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: methotrexate\nDrug type: small_molecule\nCondition: Childhood T Acute Lymphoblastic Leukemia\nTherapeutic area: oncology", "metadata": {"intervention_id": 566, "condition_id": 9814, "intervention_name": "methotrexate", "condition_name": "Childhood T Acute Lymphoblastic Leukemia", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2024}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0156", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Paclitaxel\nDrug type: small_molecule\nCondition: Stage IV Breast Cancer AJCC v6 and v7\nTherapeutic area: oncology", "metadata": {"intervention_id": 32, "condition_id": 5465, "intervention_name": "Paclitaxel", "condition_name": "Stage IV Breast Cancer AJCC v6 and v7", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2017}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0157", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Cyclophosphamide\nDrug type: small_molecule\nCondition: Ependymoma\nTherapeutic area: other", "metadata": {"intervention_id": 31, "condition_id": 2513, "intervention_name": "Cyclophosphamide", "condition_name": "Ependymoma", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2026}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0158", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: [225Ac]-FPI-1966\nCondition: Colorectal Cancer\nTherapeutic area: oncology", "metadata": {"intervention_id": 60665, "condition_id": 537, "intervention_name": "[225Ac]-FPI-1966", "condition_name": "Colorectal Cancer", "molecular_type": null, "therapeutic_area": "oncology", "earliest_year": 2023}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0159", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: bortezomib\nDrug type: small_molecule\nCondition: AL Amyloidosis\nTherapeutic area: other", "metadata": {"intervention_id": 1646, "condition_id": 13826, "intervention_name": "bortezomib", "condition_name": "AL Amyloidosis", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2017}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0160", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: FMISO\nDrug type: small_molecule\nCondition: Adult Giant Cell Glioblastoma\nTherapeutic area: other", "metadata": {"intervention_id": 58676, "condition_id": 3551, "intervention_name": "FMISO", "condition_name": "Adult Giant Cell Glioblastoma", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2018}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0161", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Durvalumab\nDrug type: monoclonal_antibody\nCondition: Clinical Stage III Cutaneous Melanoma AJCC v8\nTherapeutic area: oncology", "metadata": {"intervention_id": 267, "condition_id": 12151, "intervention_name": "Durvalumab", "condition_name": "Clinical Stage III Cutaneous Melanoma AJCC v8", "molecular_type": "monoclonal_antibody", "therapeutic_area": "oncology", "earliest_year": 2025}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0162", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Sulindac\nDrug type: small_molecule\nCondition: Tobacco Use Disorder\nTherapeutic area: other", "metadata": {"intervention_id": 2140, "condition_id": 632, "intervention_name": "Sulindac", "condition_name": "Tobacco Use Disorder", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2010}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0163", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: ACZONE (dapsone) Gel, 5%\nCondition: Non-Small-Cell Lung Cancer\nTherapeutic area: oncology", "metadata": {"intervention_id": 36641, "condition_id": 1187, "intervention_name": "ACZONE (dapsone) Gel, 5%", "condition_name": "Non-Small-Cell Lung Cancer", "molecular_type": null, "therapeutic_area": "oncology", "earliest_year": 2007}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0164", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Cyclophosphamide\nDrug type: small_molecule\nCondition: Germinal Center B-cell Type (GCB)\nTherapeutic area: other", "metadata": {"intervention_id": 31, "condition_id": 15210, "intervention_name": "Cyclophosphamide", "condition_name": "Germinal Center B-cell Type (GCB)", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2023}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0165", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Paclitaxel\nDrug type: small_molecule\nCondition: Endometrial Clear Cell Adenocarcinoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 32, "condition_id": 12113, "intervention_name": "Paclitaxel", "condition_name": "Endometrial Clear Cell Adenocarcinoma", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2023}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0166", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Gonal-F®\nDrug type: peptide\nCondition: Monofollicular Development\nTherapeutic area: other", "metadata": {"intervention_id": 5387, "condition_id": 38194, "intervention_name": "Gonal-F®", "condition_name": "Monofollicular Development", "molecular_type": "peptide", "therapeutic_area": "other", "earliest_year": 2014}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0167", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Carboplatin\nDrug type: small_molecule\nCondition: Stage II Breast Cancer AJCC v6 and v7\nTherapeutic area: oncology", "metadata": {"intervention_id": 148, "condition_id": 8195, "intervention_name": "Carboplatin", "condition_name": "Stage II Breast Cancer AJCC v6 and v7", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2026}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0168", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Topotecan\nDrug type: small_molecule\nCondition: Micropapillary Serous Carcinoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 1576, "condition_id": 17652, "intervention_name": "Topotecan", "condition_name": "Micropapillary Serous Carcinoma", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2025}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0169", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Decitabine\nDrug type: small_molecule\nCondition: Previously Treated Myelodysplastic Syndromes\nTherapeutic area: other", "metadata": {"intervention_id": 809, "condition_id": 2577, "intervention_name": "Decitabine", "condition_name": "Previously Treated Myelodysplastic Syndromes", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2013}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0170", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Imatinib\nDrug type: small_molecule\nCondition: Thyroid Cancer\nTherapeutic area: oncology", "metadata": {"intervention_id": 2433, "condition_id": 1622, "intervention_name": "Imatinib", "condition_name": "Thyroid Cancer", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2010}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0171", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Ursodeoxycholic acid\nDrug type: small_molecule\nCondition: Primary Sclerosing Cholangitis\nTherapeutic area: other", "metadata": {"intervention_id": 7533, "condition_id": 9407, "intervention_name": "Ursodeoxycholic acid", "condition_name": "Primary Sclerosing Cholangitis", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2008}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0172", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Microbiota-based Formulation RBX7455\nCondition: Prognostic Stage IIIC Breast Cancer AJCC v8\nTherapeutic area: oncology", "metadata": {"intervention_id": 126949, "condition_id": 4150, "intervention_name": "Microbiota-based Formulation RBX7455", "condition_name": "Prognostic Stage IIIC Breast Cancer AJCC v8", "molecular_type": null, "therapeutic_area": "oncology", "earliest_year": 2023}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0173", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: irinotecan hydrochloride\nDrug type: small_molecule\nCondition: Metastatic Renal Cell Carcinoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 2956, "condition_id": 185, "intervention_name": "irinotecan hydrochloride", "condition_name": "Metastatic Renal Cell Carcinoma", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2024}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0174", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Recombinant EphB4-HSA Fusion Protein\nDrug type: unknown\nCondition: EGFR Gene Mutation\nTherapeutic area: other", "metadata": {"intervention_id": 47660, "condition_id": 11640, "intervention_name": "Recombinant EphB4-HSA Fusion Protein", "condition_name": "EGFR Gene Mutation", "molecular_type": "unknown", "therapeutic_area": "other", "earliest_year": 2024}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0175", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Letrozole\nDrug type: small_molecule\nCondition: Stage IIIB Breast Cancer AJCC v7\nTherapeutic area: oncology", "metadata": {"intervention_id": 1977, "condition_id": 15942, "intervention_name": "Letrozole", "condition_name": "Stage IIIB Breast Cancer AJCC v7", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2030}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0176", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Carboplatin\nDrug type: small_molecule\nCondition: Undifferentiated Ovarian Carcinoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 148, "condition_id": 19082, "intervention_name": "Carboplatin", "condition_name": "Undifferentiated Ovarian Carcinoma", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2015}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0177", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Carboplatin\nDrug type: small_molecule\nCondition: Metastatic Laryngeal Squamous Cell Carcinoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 148, "condition_id": 38677, "intervention_name": "Carboplatin", "condition_name": "Metastatic Laryngeal Squamous Cell Carcinoma", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2026}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0178", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: non-pegylated liposomal doxorubicon (Myocet™)\nCondition: HER2 Positive Metastatic Breast Cancer\nTherapeutic area: oncology", "metadata": {"intervention_id": 53823, "condition_id": 9380, "intervention_name": "non-pegylated liposomal doxorubicon (Myocet™)", "condition_name": "HER2 Positive Metastatic Breast Cancer", "molecular_type": null, "therapeutic_area": "oncology", "earliest_year": 2014}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0179", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: fludarabine phosphate\nDrug type: small_molecule\nCondition: Stage IV Mycosis Fungoides/Sezary Syndrome\nTherapeutic area: other", "metadata": {"intervention_id": 743, "condition_id": 5438, "intervention_name": "fludarabine phosphate", "condition_name": "Stage IV Mycosis Fungoides/Sezary Syndrome", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2017}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0180", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Paclitaxel\nDrug type: small_molecule\nCondition: Neuroendocrine Carcinoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 32, "condition_id": 4300, "intervention_name": "Paclitaxel", "condition_name": "Neuroendocrine Carcinoma", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2025}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0181", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: bupropion extra long (XL)\nCondition: Major Depressive Disorder\nTherapeutic area: other", "metadata": {"intervention_id": 43182, "condition_id": 346, "intervention_name": "bupropion extra long (XL)", "condition_name": "Major Depressive Disorder", "molecular_type": null, "therapeutic_area": "other", "earliest_year": 2012}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0182", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: BAY 1000394\nDrug type: small_molecule\nCondition: Solid Tumor\nTherapeutic area: oncology", "metadata": {"intervention_id": 61255, "condition_id": 345, "intervention_name": "BAY 1000394", "condition_name": "Solid Tumor", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2023}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0183", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Memantine (twice daily)\nDrug type: small_molecule\nCondition: Alzheimer Dementia (AD)\nTherapeutic area: neurology", "metadata": {"intervention_id": 175489, "condition_id": 25330, "intervention_name": "Memantine (twice daily)", "condition_name": "Alzheimer Dementia (AD)", "molecular_type": "small_molecule", "therapeutic_area": "neurology", "earliest_year": 2016}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0184", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Nicotine polacrilex\nDrug type: unknown\nCondition: Nicotine Addiction\nTherapeutic area: other", "metadata": {"intervention_id": 29213, "condition_id": 12000, "intervention_name": "Nicotine polacrilex", "condition_name": "Nicotine Addiction", "molecular_type": "unknown", "therapeutic_area": "other", "earliest_year": 2013}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0185", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Cyclophosphamide\nDrug type: small_molecule\nCondition: Stiff-Person Syndrome\nTherapeutic area: other", "metadata": {"intervention_id": 31, "condition_id": 30738, "intervention_name": "Cyclophosphamide", "condition_name": "Stiff-Person Syndrome", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2019}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0186", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Durvalumab\nDrug type: monoclonal_antibody\nCondition: Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8\nTherapeutic area: oncology", "metadata": {"intervention_id": 267, "condition_id": 26861, "intervention_name": "Durvalumab", "condition_name": "Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8", "molecular_type": "monoclonal_antibody", "therapeutic_area": "oncology", "earliest_year": 2025}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0187", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Pterostilbene\nDrug type: small_molecule\nCondition: Atypical Endometrial Hyperplasia\nTherapeutic area: other", "metadata": {"intervention_id": 91317, "condition_id": 15760, "intervention_name": "Pterostilbene", "condition_name": "Atypical Endometrial Hyperplasia", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2026}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0188", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: dasatinib\nDrug type: small_molecule\nCondition: Adult Glioblastoma\nTherapeutic area: other", "metadata": {"intervention_id": 2768, "condition_id": 3552, "intervention_name": "dasatinib", "condition_name": "Adult Glioblastoma", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2018}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0189", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Pioglitazone\nDrug type: small_molecule\nCondition: Squamous Cell Carcinoma of the Skin\nTherapeutic area: oncology", "metadata": {"intervention_id": 1529, "condition_id": 11198, "intervention_name": "Pioglitazone", "condition_name": "Squamous Cell Carcinoma of the Skin", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2019}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0190", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Epacadostat\nDrug type: small_molecule\nCondition: Ovarian Cancer\nTherapeutic area: oncology", "metadata": {"intervention_id": 4890, "condition_id": 575, "intervention_name": "Epacadostat", "condition_name": "Ovarian Cancer", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2014}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0191", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Intravenous methyl prednisolone\nCondition: Microscopic Polyangiitis\nTherapeutic area: other", "metadata": {"intervention_id": 148780, "condition_id": 10972, "intervention_name": "Intravenous methyl prednisolone", "condition_name": "Microscopic Polyangiitis", "molecular_type": null, "therapeutic_area": "other", "earliest_year": 2003}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0192", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: NIS793\nDrug type: monoclonal_antibody\nCondition: Post-polycythemia Vera Myelofibrosis\nTherapeutic area: other", "metadata": {"intervention_id": 7486, "condition_id": 4955, "intervention_name": "NIS793", "condition_name": "Post-polycythemia Vera Myelofibrosis", "molecular_type": "monoclonal_antibody", "therapeutic_area": "other", "earliest_year": 2024}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0193", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: SGN-CD228A\nDrug type: unknown\nCondition: Pleural Mesothelioma\nTherapeutic area: other", "metadata": {"intervention_id": 145359, "condition_id": 7283, "intervention_name": "SGN-CD228A", "condition_name": "Pleural Mesothelioma", "molecular_type": "unknown", "therapeutic_area": "other", "earliest_year": 2023}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0194", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: AZD1480 BID\nDrug type: small_molecule\nCondition: Solid Tumour\nTherapeutic area: oncology", "metadata": {"intervention_id": 81242, "condition_id": 28, "intervention_name": "AZD1480 BID", "condition_name": "Solid Tumour", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2012}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0195", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: [68Ga]Ga-EVS459\nCondition: Ovarian Cancer\nTherapeutic area: oncology", "metadata": {"intervention_id": 18243, "condition_id": 575, "intervention_name": "[68Ga]Ga-EVS459", "condition_name": "Ovarian Cancer", "molecular_type": null, "therapeutic_area": "oncology", "earliest_year": 2025}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0196", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Tumescent Solution with dilute epinephrine\nCondition: Postoperative Nausea and Vomiting\nTherapeutic area: other", "metadata": {"intervention_id": 132774, "condition_id": 1241, "intervention_name": "Tumescent Solution with dilute epinephrine", "condition_name": "Postoperative Nausea and Vomiting", "molecular_type": null, "therapeutic_area": "other", "earliest_year": 2014}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0197", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Furosemide Injection\nCondition: Cirrhosis, Liver\nTherapeutic area: other", "metadata": {"intervention_id": 8956, "condition_id": 1648, "intervention_name": "Furosemide Injection", "condition_name": "Cirrhosis, Liver", "molecular_type": null, "therapeutic_area": "other", "earliest_year": 2024}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0198", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Ruxolitinib Cream\nDrug type: small_molecule\nCondition: Prurigo Nodularis\nTherapeutic area: other", "metadata": {"intervention_id": 244, "condition_id": 4992, "intervention_name": "Ruxolitinib Cream", "condition_name": "Prurigo Nodularis", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2025}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0199", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Semaglutide Injectable Product\nCondition: Atrial Fibrillation\nTherapeutic area: cardiology", "metadata": {"intervention_id": 6778, "condition_id": 433, "intervention_name": "Semaglutide Injectable Product", "condition_name": "Atrial Fibrillation", "molecular_type": null, "therapeutic_area": "cardiology", "earliest_year": 2024}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0200", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Prednisone\nDrug type: small_molecule\nCondition: Recurrent Adult Lymphoblastic Lymphoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 165, "condition_id": 2048, "intervention_name": "Prednisone", "condition_name": "Recurrent Adult Lymphoblastic Lymphoma", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2024}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0201", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Nitric Oxide\nDrug type: small_molecule\nCondition: Oxidative Injury\nTherapeutic area: other", "metadata": {"intervention_id": 5321, "condition_id": 53234, "intervention_name": "Nitric Oxide", "condition_name": "Oxidative Injury", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2015}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0202", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Glutathione\nDrug type: small_molecule\nCondition: Stage IIIA Ovarian Cancer\nTherapeutic area: oncology", "metadata": {"intervention_id": 3725, "condition_id": 3629, "intervention_name": "Glutathione", "condition_name": "Stage IIIA Ovarian Cancer", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2012}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0203", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Ranolazine\nDrug type: small_molecule\nCondition: Atrial Fibrillation New Onset\nTherapeutic area: cardiology", "metadata": {"intervention_id": 6531, "condition_id": 95, "intervention_name": "Ranolazine", "condition_name": "Atrial Fibrillation New Onset", "molecular_type": "small_molecule", "therapeutic_area": "cardiology", "earliest_year": 2015}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0204", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Preladenant\nDrug type: small_molecule\nCondition: Akathisia, Drug-Induced\nTherapeutic area: other", "metadata": {"intervention_id": 21231, "condition_id": 8341, "intervention_name": "Preladenant", "condition_name": "Akathisia, Drug-Induced", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2008}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0205", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Eribulin\nDrug type: small_molecule\nCondition: Metastatic Malignant Solid Neoplasm\nTherapeutic area: oncology", "metadata": {"intervention_id": 967, "condition_id": 4374, "intervention_name": "Eribulin", "condition_name": "Metastatic Malignant Solid Neoplasm", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2024}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0206", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Non-surgical periodontal treatment and azithromycin treatment\nCondition: Severe Chronic Periodontitis\nTherapeutic area: other", "metadata": {"intervention_id": 105792, "condition_id": 25128, "intervention_name": "Non-surgical periodontal treatment and azithromycin treatment", "condition_name": "Severe Chronic Periodontitis", "molecular_type": null, "therapeutic_area": "other", "earliest_year": 2023}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0207", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Pembrolizumab\nDrug type: monoclonal_antibody\nCondition: Refractory Urothelial Carcinoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 122, "condition_id": 22756, "intervention_name": "Pembrolizumab", "condition_name": "Refractory Urothelial Carcinoma", "molecular_type": "monoclonal_antibody", "therapeutic_area": "oncology", "earliest_year": 2024}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0208", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Pamiparib\nDrug type: small_molecule\nCondition: Stage IV Renal Cell Cancer AJCC v8\nTherapeutic area: oncology", "metadata": {"intervention_id": 16549, "condition_id": 6806, "intervention_name": "Pamiparib", "condition_name": "Stage IV Renal Cell Cancer AJCC v8", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2023}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0209", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Carboplatin\nDrug type: small_molecule\nCondition: Non-small Cell Lung Cancer (NSCLC)\nTherapeutic area: oncology", "metadata": {"intervention_id": 148, "condition_id": 3360, "intervention_name": "Carboplatin", "condition_name": "Non-small Cell Lung Cancer (NSCLC)", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2025}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0210", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Docetaxel\nDrug type: small_molecule\nCondition: Recurrent Salivary Gland Carcinoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 729, "condition_id": 471, "intervention_name": "Docetaxel", "condition_name": "Recurrent Salivary Gland Carcinoma", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2026}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0211", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Capecitabine\nDrug type: small_molecule\nCondition: Squamous Cell Carcinoma of Head and Neck\nTherapeutic area: oncology", "metadata": {"intervention_id": 679, "condition_id": 796, "intervention_name": "Capecitabine", "condition_name": "Squamous Cell Carcinoma of Head and Neck", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2025}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0212", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Metformin\nDrug type: small_molecule\nCondition: Metastatic Renal Cell Carcinoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 68, "condition_id": 185, "intervention_name": "Metformin", "condition_name": "Metastatic Renal Cell Carcinoma", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2023}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0213", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Chemotherapy\nDrug type: unknown\nCondition: Stage IIIA Breast Cancer\nTherapeutic area: oncology", "metadata": {"intervention_id": 476, "condition_id": 4903, "intervention_name": "Chemotherapy", "condition_name": "Stage IIIA Breast Cancer", "molecular_type": "unknown", "therapeutic_area": "oncology", "earliest_year": 2013}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0214", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Cetuximab\nDrug type: monoclonal_antibody\nCondition: Stage III Squamous Cell Carcinoma of the Hypopharynx\nTherapeutic area: oncology", "metadata": {"intervention_id": 208, "condition_id": 226, "intervention_name": "Cetuximab", "condition_name": "Stage III Squamous Cell Carcinoma of the Hypopharynx", "molecular_type": "monoclonal_antibody", "therapeutic_area": "oncology", "earliest_year": 2019}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0215", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Total Body Irradiation (TBI)\nCondition: Myelodysplastic Syndromes (MDS) Other Than RA or RARS Subtypes\nTherapeutic area: other", "metadata": {"intervention_id": 6705, "condition_id": 33393, "intervention_name": "Total Body Irradiation (TBI)", "condition_name": "Myelodysplastic Syndromes (MDS) Other Than RA or RARS Subtypes", "molecular_type": null, "therapeutic_area": "other", "earliest_year": 2012}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0216", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Intralipid\nCondition: Essential Fatty Acid Deficiency (EFAD)\nTherapeutic area: other", "metadata": {"intervention_id": 10626, "condition_id": 20890, "intervention_name": "Intralipid", "condition_name": "Essential Fatty Acid Deficiency (EFAD)", "molecular_type": null, "therapeutic_area": "other", "earliest_year": 2016}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0217", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Sodium Thiosulfate\nDrug type: small_molecule\nCondition: Lymphoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 4106, "condition_id": 26, "intervention_name": "Sodium Thiosulfate", "condition_name": "Lymphoma", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2010}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0218", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Ponatinib\nDrug type: small_molecule\nCondition: Leukemia, Myeloid, Chronic-Phase\nTherapeutic area: oncology", "metadata": {"intervention_id": 8611, "condition_id": 11263, "intervention_name": "Ponatinib", "condition_name": "Leukemia, Myeloid, Chronic-Phase", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2023}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0219", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Tirosint®-SOL\nDrug type: small_molecule\nCondition: Congenital Hypothyroidism\nTherapeutic area: other", "metadata": {"intervention_id": 55219, "condition_id": 7824, "intervention_name": "Tirosint®-SOL", "condition_name": "Congenital Hypothyroidism", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2025}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0220", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Topotecan\nDrug type: small_molecule\nCondition: Primary Peritoneal Carcinoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 1576, "condition_id": 2367, "intervention_name": "Topotecan", "condition_name": "Primary Peritoneal Carcinoma", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2024}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0221", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: nebulisation of terbutaline\nCondition: Asthma in Children\nTherapeutic area: respiratory", "metadata": {"intervention_id": 161883, "condition_id": 5695, "intervention_name": "nebulisation of terbutaline", "condition_name": "Asthma in Children", "molecular_type": null, "therapeutic_area": "respiratory", "earliest_year": 2023}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0222", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Paclitaxel\nDrug type: small_molecule\nCondition: Esophageal Squamous Cell Carcinoma (ESCC)\nTherapeutic area: oncology", "metadata": {"intervention_id": 32, "condition_id": 8756, "intervention_name": "Paclitaxel", "condition_name": "Esophageal Squamous Cell Carcinoma (ESCC)", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2024}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0223", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Vatiquinone\nDrug type: small_molecule\nCondition: Mitochondrial Encephalopathy (MELAS)\nTherapeutic area: other", "metadata": {"intervention_id": 39544, "condition_id": 2540, "intervention_name": "Vatiquinone", "condition_name": "Mitochondrial Encephalopathy (MELAS)", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2023}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0224", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Prasugrel\nDrug type: small_molecule\nCondition: Cardiovascular Disease\nTherapeutic area: other", "metadata": {"intervention_id": 4125, "condition_id": 10, "intervention_name": "Prasugrel", "condition_name": "Cardiovascular Disease", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2013}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0225", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Leuprolide Open Label\nDrug type: peptide\nCondition: Cancer of the Prostate\nTherapeutic area: oncology", "metadata": {"intervention_id": 140713, "condition_id": 12116, "intervention_name": "Leuprolide Open Label", "condition_name": "Cancer of the Prostate", "molecular_type": "peptide", "therapeutic_area": "oncology", "earliest_year": 2026}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0226", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: BLZ945\nDrug type: small_molecule\nCondition: Amyotrophic Lateral Sclerosis\nTherapeutic area: other", "metadata": {"intervention_id": 37975, "condition_id": 485, "intervention_name": "BLZ945", "condition_name": "Amyotrophic Lateral Sclerosis", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2024}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0227", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Bevacizumab\nDrug type: monoclonal_antibody\nCondition: Age Related Macular Degeneration\nTherapeutic area: other", "metadata": {"intervention_id": 28, "condition_id": 1669, "intervention_name": "Bevacizumab", "condition_name": "Age Related Macular Degeneration", "molecular_type": "monoclonal_antibody", "therapeutic_area": "other", "earliest_year": 2015}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0228", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Brinzolamide 1%/brimonidine tartrate 0.2% ophthalmic suspension\nCondition: Open-Angle Glaucoma\nTherapeutic area: other", "metadata": {"intervention_id": 39551, "condition_id": 3929, "intervention_name": "Brinzolamide 1%/brimonidine tartrate 0.2% ophthalmic suspension", "condition_name": "Open-Angle Glaucoma", "molecular_type": null, "therapeutic_area": "other", "earliest_year": 2018}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0229", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: [14C] Subasumstat\nCondition: Solid Tumors\nTherapeutic area: oncology", "metadata": {"intervention_id": 115210, "condition_id": 479, "intervention_name": "[14C] Subasumstat", "condition_name": "Solid Tumors", "molecular_type": null, "therapeutic_area": "oncology", "earliest_year": 2024}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0230", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: M5049 high dose\nCondition: Dermatomyositis\nTherapeutic area: other", "metadata": {"intervention_id": 68113, "condition_id": 1900, "intervention_name": "M5049 high dose", "condition_name": "Dermatomyositis", "molecular_type": null, "therapeutic_area": "other", "earliest_year": 2025}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0231", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Topotecan\nDrug type: small_molecule\nCondition: Pediatric Cancer\nTherapeutic area: oncology", "metadata": {"intervention_id": 1576, "condition_id": 500, "intervention_name": "Topotecan", "condition_name": "Pediatric Cancer", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2025}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0232", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Exenatide once weekly suspension\nCondition: Diabetes Type 2\nTherapeutic area: metabolic", "metadata": {"intervention_id": 36335, "condition_id": 409, "intervention_name": "Exenatide once weekly suspension", "condition_name": "Diabetes Type 2", "molecular_type": null, "therapeutic_area": "metabolic", "earliest_year": 2014}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0233", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Pemetrexed\nDrug type: small_molecule\nCondition: Non-Small Cell Lung Cancer Metastatic\nTherapeutic area: oncology", "metadata": {"intervention_id": 147, "condition_id": 5857, "intervention_name": "Pemetrexed", "condition_name": "Non-Small Cell Lung Cancer Metastatic", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2019}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0234", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: LY2599666\nDrug type: unknown\nCondition: Healthy\nTherapeutic area: other", "metadata": {"intervention_id": 58020, "condition_id": 8, "intervention_name": "LY2599666", "condition_name": "Healthy", "molecular_type": "unknown", "therapeutic_area": "other", "earliest_year": 2016}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0235", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: standard saline\nCondition: Chronic Obstructive Pulmonary Disease\nTherapeutic area: respiratory", "metadata": {"intervention_id": 29875, "condition_id": 329, "intervention_name": "standard saline", "condition_name": "Chronic Obstructive Pulmonary Disease", "molecular_type": null, "therapeutic_area": "respiratory", "earliest_year": 2017}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0236", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Carboplatin\nDrug type: small_molecule\nCondition: Grade 3b Follicular Lymphoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 148, "condition_id": 23045, "intervention_name": "Carboplatin", "condition_name": "Grade 3b Follicular Lymphoma", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2023}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0237", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: mycophenolate mofetil\nDrug type: small_molecule\nCondition: Chronic Myelogenous Leukemia\nTherapeutic area: oncology", "metadata": {"intervention_id": 744, "condition_id": 4653, "intervention_name": "mycophenolate mofetil", "condition_name": "Chronic Myelogenous Leukemia", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2014}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0238", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Trilaciclib\nDrug type: small_molecule\nCondition: Metastatic Bladder Cancer\nTherapeutic area: oncology", "metadata": {"intervention_id": 11817, "condition_id": 1514, "intervention_name": "Trilaciclib", "condition_name": "Metastatic Bladder Cancer", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2024}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0239", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Dordaviprone (ONC201)\nDrug type: small_molecule\nCondition: Thalamic Glioma\nTherapeutic area: oncology", "metadata": {"intervention_id": 25847, "condition_id": 43443, "intervention_name": "Dordaviprone (ONC201)", "condition_name": "Thalamic Glioma", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2023}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0240", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: metformin up to 2500mg/d\nCondition: Head and Neck Neoplasms\nTherapeutic area: oncology", "metadata": {"intervention_id": 5333, "condition_id": 616, "intervention_name": "metformin up to 2500mg/d", "condition_name": "Head and Neck Neoplasms", "molecular_type": null, "therapeutic_area": "oncology", "earliest_year": 2014}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0241", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: Tenofovir alafenamide (TAF)\nDrug type: small_molecule\nCondition: Hepatitis B, Chronic\nTherapeutic area: infectious", "metadata": {"intervention_id": 66531, "condition_id": 1689, "intervention_name": "Tenofovir alafenamide (TAF)", "condition_name": "Hepatitis B, Chronic", "molecular_type": "small_molecule", "therapeutic_area": "infectious", "earliest_year": 2023}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0242", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: aldesleukin\nDrug type: peptide\nCondition: Metastatic Melanoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 387, "condition_id": 220, "intervention_name": "aldesleukin", "condition_name": "Metastatic Melanoma", "molecular_type": "peptide", "therapeutic_area": "oncology", "earliest_year": 2011}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0243", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: GM-CSF\nDrug type: peptide\nCondition: Pediatric Sepsis-induced Multiple Organ Dysfunction Syndrome\nTherapeutic area: other", "metadata": {"intervention_id": 5109, "condition_id": 44292, "intervention_name": "GM-CSF", "condition_name": "Pediatric Sepsis-induced Multiple Organ Dysfunction Syndrome", "molecular_type": "peptide", "therapeutic_area": "other", "earliest_year": 2024}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0244", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Selegiline + nicotine replacement therapy\nCondition: Nicotine Dependence\nTherapeutic area: other", "metadata": {"intervention_id": 155538, "condition_id": 2480, "intervention_name": "Selegiline + nicotine replacement therapy", "condition_name": "Nicotine Dependence", "molecular_type": null, "therapeutic_area": "other", "earliest_year": 2008}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0245", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Midodrine HCl\nDrug type: small_molecule\nCondition: Symptomatic Orthostatic Hypotension\nTherapeutic area: other", "metadata": {"intervention_id": 337, "condition_id": 8596, "intervention_name": "Midodrine HCl", "condition_name": "Symptomatic Orthostatic Hypotension", "molecular_type": "small_molecule", "therapeutic_area": "other", "earliest_year": 2013}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0246", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: canakinumab (anti IL-1beta)\nDrug type: monoclonal_antibody\nCondition: Preservation of Insulin Secretion\nTherapeutic area: other", "metadata": {"intervention_id": 159883, "condition_id": 50601, "intervention_name": "canakinumab (anti IL-1beta)", "condition_name": "Preservation of Insulin Secretion", "molecular_type": "monoclonal_antibody", "therapeutic_area": "other", "earliest_year": 2013}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0247", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: Sirolimus\nDrug type: small_molecule\nCondition: Stage II Contiguous Adult Diffuse Mixed Cell Lymphoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 55, "condition_id": 18495, "intervention_name": "Sirolimus", "condition_name": "Stage II Contiguous Adult Diffuse Mixed Cell Lymphoma", "molecular_type": "small_molecule", "therapeutic_area": "oncology", "earliest_year": 2015}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0248", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "post_2023", "context_text": "Drug: difelikefalin 2.0 mg tablets\nCondition: Notalgia Paresthetica\nTherapeutic area: other", "metadata": {"intervention_id": 141506, "condition_id": 9969, "intervention_name": "difelikefalin 2.0 mg tablets", "condition_name": "Notalgia Paresthetica", "molecular_type": null, "therapeutic_area": "other", "earliest_year": 2024}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0249", "task": "CT-L4", "gold_answer": "tested", "gold_category": null, "difficulty": null, "temporal_group": "pre_2020", "context_text": "Drug: FS VH S/D 500 s-apr, 60-seconds polymerization time\nCondition: Adjunct to Hemostasis in Vascular Surgery (Synthetic Vascular Grafts)\nTherapeutic area: other", "metadata": {"intervention_id": 126715, "condition_id": 34836, "intervention_name": "FS VH S/D 500 s-apr, 60-seconds polymerization time", "condition_name": "Adjunct to Hemostasis in Vascular Surgery (Synthetic Vascular Grafts)", "molecular_type": null, "therapeutic_area": "other", "earliest_year": 2008}, "untested_type": null, "split": "test"} | |
| {"question_id": "CTL4-0250", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: BAT1308\nDrug type: monoclonal_antibody\nCondition: Major Coronary Event\nTherapeutic area: cardiology", "metadata": {"intervention_id": 310, "condition_id": 54727, "intervention_name": "BAT1308", "condition_name": "Major Coronary Event", "molecular_type": "monoclonal_antibody", "therapeutic_area": "cardiology"}, "untested_type": "obvious", "split": "fewshot"} | |
| {"question_id": "CTL4-0251", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Sunitinib\nDrug type: small_molecule\nCondition: Relapsed B-cell Acute Lymphoblastic Leukemia After CD19 CAR-T ACI\nTherapeutic area: oncology", "metadata": {"intervention_id": 1728, "condition_id": 49007, "intervention_name": "Sunitinib", "condition_name": "Relapsed B-cell Acute Lymphoblastic Leukemia After CD19 CAR-T ACI", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "fewshot"} | |
| {"question_id": "CTL4-0252", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Metformin Hydrochloride\nDrug type: small_molecule\nCondition: Small Intestinal Squamous Cell Carcinoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 348, "condition_id": 38635, "intervention_name": "Metformin Hydrochloride", "condition_name": "Small Intestinal Squamous Cell Carcinoma", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "fewshot"} | |
| {"question_id": "CTL4-0253", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: sugar pill\nCondition: Short Telomere Length\nTherapeutic area: other", "metadata": {"intervention_id": 530, "condition_id": 10122, "intervention_name": "sugar pill", "condition_name": "Short Telomere Length", "molecular_type": null, "therapeutic_area": "other"}, "untested_type": "trick", "split": "fewshot"} | |
| {"question_id": "CTL4-0254", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Vemurafenib\nDrug type: small_molecule\nCondition: Stage IVA Vulvar Cancer AJCC v7\nTherapeutic area: oncology", "metadata": {"intervention_id": 517, "condition_id": 39676, "intervention_name": "Vemurafenib", "condition_name": "Stage IVA Vulvar Cancer AJCC v7", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "fewshot"} | |
| {"question_id": "CTL4-0255", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Zavegepant\nDrug type: small_molecule\nCondition: Chronic Viral Hepatitis B With Delta-agent\nTherapeutic area: infectious", "metadata": {"intervention_id": 2276, "condition_id": 29653, "intervention_name": "Zavegepant", "condition_name": "Chronic Viral Hepatitis B With Delta-agent", "molecular_type": "small_molecule", "therapeutic_area": "infectious"}, "untested_type": "obvious", "split": "fewshot"} | |
| {"question_id": "CTL4-0256", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Solifenacin Succinate (VESIcare)\nDrug type: small_molecule\nCondition: Chronic Hepatitis\nTherapeutic area: infectious", "metadata": {"intervention_id": 2167, "condition_id": 4408, "intervention_name": "Solifenacin Succinate (VESIcare)", "condition_name": "Chronic Hepatitis", "molecular_type": "small_molecule", "therapeutic_area": "infectious"}, "untested_type": "obvious", "split": "fewshot"} | |
| {"question_id": "CTL4-0257", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Frovatriptan\nDrug type: small_molecule\nCondition: Pulmonary Tuberculosis TB in Sputum: (+) Microscopy\nTherapeutic area: infectious", "metadata": {"intervention_id": 3363, "condition_id": 38361, "intervention_name": "Frovatriptan", "condition_name": "Pulmonary Tuberculosis TB in Sputum: (+) Microscopy", "molecular_type": "small_molecule", "therapeutic_area": "infectious"}, "untested_type": "obvious", "split": "fewshot"} | |
| {"question_id": "CTL4-0258", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Psilocybin\nDrug type: small_molecule\nCondition: Stenosing Tenosynovitis\nTherapeutic area: other", "metadata": {"intervention_id": 452, "condition_id": 29496, "intervention_name": "Psilocybin", "condition_name": "Stenosing Tenosynovitis", "molecular_type": "small_molecule", "therapeutic_area": "other"}, "untested_type": "trick", "split": "fewshot"} | |
| {"question_id": "CTL4-0259", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Empagliflozin\nDrug type: small_molecule\nCondition: Recent Onset type1 Diabetes\nTherapeutic area: metabolic", "metadata": {"intervention_id": 482, "condition_id": 52100, "intervention_name": "Empagliflozin", "condition_name": "Recent Onset type1 Diabetes", "molecular_type": "small_molecule", "therapeutic_area": "metabolic"}, "untested_type": "trick", "split": "fewshot"} | |
| {"question_id": "CTL4-0260", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Preladenant 5 mg tablet\nCondition: Immune Response to Influenza Vaccine\nTherapeutic area: infectious", "metadata": {"intervention_id": 4405, "condition_id": 42888, "intervention_name": "Preladenant 5 mg tablet", "condition_name": "Immune Response to Influenza Vaccine", "molecular_type": null, "therapeutic_area": "infectious"}, "untested_type": "obvious", "split": "fewshot"} | |
| {"question_id": "CTL4-0261", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: ART\nDrug type: small_molecule\nCondition: Temporal Lobe Epilepsy\nTherapeutic area: neurology", "metadata": {"intervention_id": 2198, "condition_id": 45576, "intervention_name": "ART", "condition_name": "Temporal Lobe Epilepsy", "molecular_type": "small_molecule", "therapeutic_area": "neurology"}, "untested_type": "obvious", "split": "fewshot"} | |
| {"question_id": "CTL4-0262", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Calcipotriene\nDrug type: small_molecule\nCondition: Pregnancy in Diabetes\nTherapeutic area: metabolic", "metadata": {"intervention_id": 942, "condition_id": 37255, "intervention_name": "Calcipotriene", "condition_name": "Pregnancy in Diabetes", "molecular_type": "small_molecule", "therapeutic_area": "metabolic"}, "untested_type": "obvious", "split": "fewshot"} | |
| {"question_id": "CTL4-0263", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: 2%Tofacitinib Ointment\nCondition: Pregestational Obesity (BMI > 27kg/m2)\nTherapeutic area: metabolic", "metadata": {"intervention_id": 7832, "condition_id": 4431, "intervention_name": "2%Tofacitinib Ointment", "condition_name": "Pregestational Obesity (BMI > 27kg/m2)", "molecular_type": null, "therapeutic_area": "metabolic"}, "untested_type": "obvious", "split": "fewshot"} | |
| {"question_id": "CTL4-0264", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: 5-FU\nDrug type: small_molecule\nCondition: Non Clear Cell Renal Cell Carcinoma (nccRCC)\nTherapeutic area: oncology", "metadata": {"intervention_id": 1683, "condition_id": 46732, "intervention_name": "5-FU", "condition_name": "Non Clear Cell Renal Cell Carcinoma (nccRCC)", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "fewshot"} | |
| {"question_id": "CTL4-0265", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: albiglutide\nDrug type: peptide\nCondition: System Lupus Erythematosus(SLE)\nTherapeutic area: autoimmune", "metadata": {"intervention_id": 1458, "condition_id": 39549, "intervention_name": "albiglutide", "condition_name": "System Lupus Erythematosus(SLE)", "molecular_type": "peptide", "therapeutic_area": "autoimmune"}, "untested_type": "obvious", "split": "fewshot"} | |
| {"question_id": "CTL4-0266", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Tirofiban\nDrug type: small_molecule\nCondition: Chronic HIV Infection\nTherapeutic area: infectious", "metadata": {"intervention_id": 4015, "condition_id": 25646, "intervention_name": "Tirofiban", "condition_name": "Chronic HIV Infection", "molecular_type": "small_molecule", "therapeutic_area": "infectious"}, "untested_type": "obvious", "split": "fewshot"} | |
| {"question_id": "CTL4-0267", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Cladribine\nDrug type: small_molecule\nCondition: Stage IIA Cervical Cancer AJCC v8\nTherapeutic area: oncology", "metadata": {"intervention_id": 6992, "condition_id": 45733, "intervention_name": "Cladribine", "condition_name": "Stage IIA Cervical Cancer AJCC v8", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "fewshot"} | |
| {"question_id": "CTL4-0268", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Ticagrelor\nDrug type: small_molecule\nCondition: Cervical Carcinoma, Non-SquamousType\nTherapeutic area: oncology", "metadata": {"intervention_id": 3373, "condition_id": 50440, "intervention_name": "Ticagrelor", "condition_name": "Cervical Carcinoma, Non-SquamousType", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "obvious", "split": "fewshot"} | |
| {"question_id": "CTL4-0269", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Imatinib\nDrug type: small_molecule\nCondition: Localized Advanced Rectal Adenocarcinoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 2433, "condition_id": 43663, "intervention_name": "Imatinib", "condition_name": "Localized Advanced Rectal Adenocarcinoma", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "fewshot"} | |
| {"question_id": "CTL4-0270", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: SPD489 100mg\nCondition: Asthma-COPD Overlap\nTherapeutic area: respiratory", "metadata": {"intervention_id": 5560, "condition_id": 35678, "intervention_name": "SPD489 100mg", "condition_name": "Asthma-COPD Overlap", "molecular_type": null, "therapeutic_area": "respiratory"}, "untested_type": "obvious", "split": "fewshot"} | |
| {"question_id": "CTL4-0271", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Vorinostat\nDrug type: small_molecule\nCondition: Neuroectodermal Tumor, Primitive\nTherapeutic area: oncology", "metadata": {"intervention_id": 3738, "condition_id": 33009, "intervention_name": "Vorinostat", "condition_name": "Neuroectodermal Tumor, Primitive", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "fewshot"} | |
| {"question_id": "CTL4-0272", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: isotretinoin\nDrug type: small_molecule\nCondition: Recurrent Astrocytoma\nTherapeutic area: other", "metadata": {"intervention_id": 1488, "condition_id": 40557, "intervention_name": "isotretinoin", "condition_name": "Recurrent Astrocytoma", "molecular_type": "small_molecule", "therapeutic_area": "other"}, "untested_type": "trick", "split": "fewshot"} | |
| {"question_id": "CTL4-0273", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Lorlatinib\nDrug type: small_molecule\nCondition: Intrahepatic Cholangiocellular Carcinoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 9181, "condition_id": 41938, "intervention_name": "Lorlatinib", "condition_name": "Intrahepatic Cholangiocellular Carcinoma", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "fewshot"} | |
| {"question_id": "CTL4-0274", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: dipyridamole\nDrug type: small_molecule\nCondition: Resectable Skin Squamous Cell Carcinoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 2247, "condition_id": 36136, "intervention_name": "dipyridamole", "condition_name": "Resectable Skin Squamous Cell Carcinoma", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "obvious", "split": "fewshot"} | |
| {"question_id": "CTL4-0275", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Nitric Oxide\nDrug type: small_molecule\nCondition: Electronic Cigarette\nTherapeutic area: other", "metadata": {"intervention_id": 5321, "condition_id": 17790, "intervention_name": "Nitric Oxide", "condition_name": "Electronic Cigarette", "molecular_type": "small_molecule", "therapeutic_area": "other"}, "untested_type": "trick", "split": "val"} | |
| {"question_id": "CTL4-0276", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: SNK01\nDrug type: cell_therapy\nCondition: Locally Advanced/Recurrent or Distant Metastasized Non-small Cell Lung Cancer With MET Overexpression\nTherapeutic area: oncology", "metadata": {"intervention_id": 69195, "condition_id": 8412, "intervention_name": "SNK01", "condition_name": "Locally Advanced/Recurrent or Distant Metastasized Non-small Cell Lung Cancer With MET Overexpression", "molecular_type": "cell_therapy", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "val"} | |
| {"question_id": "CTL4-0277", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Esomeprazole\nDrug type: small_molecule\nCondition: Mohs Micrographic Surgery\nTherapeutic area: other", "metadata": {"intervention_id": 2475, "condition_id": 10306, "intervention_name": "Esomeprazole", "condition_name": "Mohs Micrographic Surgery", "molecular_type": "small_molecule", "therapeutic_area": "other"}, "untested_type": "trick", "split": "val"} | |
| {"question_id": "CTL4-0278", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: rituximab\nDrug type: monoclonal_antibody\nCondition: Gastric Cancer With Hepatic Metastase\nTherapeutic area: oncology", "metadata": {"intervention_id": 400, "condition_id": 41947, "intervention_name": "rituximab", "condition_name": "Gastric Cancer With Hepatic Metastase", "molecular_type": "monoclonal_antibody", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "val"} | |
| {"question_id": "CTL4-0279", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Trametinib\nDrug type: small_molecule\nCondition: Advanced Solid Tumors or Hematologic Malignancies\nTherapeutic area: oncology", "metadata": {"intervention_id": 901, "condition_id": 19062, "intervention_name": "Trametinib", "condition_name": "Advanced Solid Tumors or Hematologic Malignancies", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "val"} | |
| {"question_id": "CTL4-0280", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Preladenant 2 mg tablet\nCondition: Obesity, COVID-19 Infection\nTherapeutic area: infectious", "metadata": {"intervention_id": 4403, "condition_id": 39657, "intervention_name": "Preladenant 2 mg tablet", "condition_name": "Obesity, COVID-19 Infection", "molecular_type": null, "therapeutic_area": "infectious"}, "untested_type": "obvious", "split": "val"} | |
| {"question_id": "CTL4-0281", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Phenylephrine\nDrug type: small_molecule\nCondition: Intestinal Failure Associated Liver Disease\nTherapeutic area: other", "metadata": {"intervention_id": 462, "condition_id": 43697, "intervention_name": "Phenylephrine", "condition_name": "Intestinal Failure Associated Liver Disease", "molecular_type": "small_molecule", "therapeutic_area": "other"}, "untested_type": "trick", "split": "val"} | |
| {"question_id": "CTL4-0282", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Cyclophosphamide\nDrug type: small_molecule\nCondition: Anterior Acute Myocardial Infarction\nTherapeutic area: cardiology", "metadata": {"intervention_id": 31, "condition_id": 30328, "intervention_name": "Cyclophosphamide", "condition_name": "Anterior Acute Myocardial Infarction", "molecular_type": "small_molecule", "therapeutic_area": "cardiology"}, "untested_type": "obvious", "split": "val"} | |
| {"question_id": "CTL4-0283", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Microcrystalline cellulose\nDrug type: unknown\nCondition: Post Stroke Delirium\nTherapeutic area: neurology", "metadata": {"intervention_id": 225, "condition_id": 47170, "intervention_name": "Microcrystalline cellulose", "condition_name": "Post Stroke Delirium", "molecular_type": "unknown", "therapeutic_area": "neurology"}, "untested_type": "obvious", "split": "val"} | |
| {"question_id": "CTL4-0284", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: eribulin mesylate\nDrug type: small_molecule\nCondition: Stage 0 Cervical Cancer\nTherapeutic area: oncology", "metadata": {"intervention_id": 5768, "condition_id": 7946, "intervention_name": "eribulin mesylate", "condition_name": "Stage 0 Cervical Cancer", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "val"} | |
| {"question_id": "CTL4-0285", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: AMXT1501\nDrug type: small_molecule\nCondition: Stage II AIDS-related Lymphoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 27537, "condition_id": 47029, "intervention_name": "AMXT1501", "condition_name": "Stage II AIDS-related Lymphoma", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "val"} | |
| {"question_id": "CTL4-0286", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Cannabidiol\nDrug type: small_molecule\nCondition: Craniofacial Pain\nTherapeutic area: other", "metadata": {"intervention_id": 7470, "condition_id": 42629, "intervention_name": "Cannabidiol", "condition_name": "Craniofacial Pain", "molecular_type": "small_molecule", "therapeutic_area": "other"}, "untested_type": "trick", "split": "val"} | |
| {"question_id": "CTL4-0287", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Avonex\nDrug type: peptide\nCondition: Pathogen Infection Covid-19 Infection\nTherapeutic area: infectious", "metadata": {"intervention_id": 1063, "condition_id": 33445, "intervention_name": "Avonex", "condition_name": "Pathogen Infection Covid-19 Infection", "molecular_type": "peptide", "therapeutic_area": "infectious"}, "untested_type": "obvious", "split": "val"} | |
| {"question_id": "CTL4-0288", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Nesiritide\nDrug type: peptide\nCondition: Stage Ⅲ Gastric Cancer\nTherapeutic area: oncology", "metadata": {"intervention_id": 1477, "condition_id": 49557, "intervention_name": "Nesiritide", "condition_name": "Stage Ⅲ Gastric Cancer", "molecular_type": "peptide", "therapeutic_area": "oncology"}, "untested_type": "obvious", "split": "val"} | |
| {"question_id": "CTL4-0289", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Tirofiban\nDrug type: small_molecule\nCondition: Advanced Malignant Tumors(Stage IA-IB)\nTherapeutic area: oncology", "metadata": {"intervention_id": 4015, "condition_id": 45316, "intervention_name": "Tirofiban", "condition_name": "Advanced Malignant Tumors(Stage IA-IB)", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "obvious", "split": "val"} | |
| {"question_id": "CTL4-0290", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Sildenafil Citrate\nDrug type: small_molecule\nCondition: Donor Hepatectomy\nTherapeutic area: other", "metadata": {"intervention_id": 690, "condition_id": 54669, "intervention_name": "Sildenafil Citrate", "condition_name": "Donor Hepatectomy", "molecular_type": "small_molecule", "therapeutic_area": "other"}, "untested_type": "trick", "split": "val"} | |
| {"question_id": "CTL4-0291", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Pralatrexate\nDrug type: small_molecule\nCondition: Gastrointestinal Tumours\nTherapeutic area: oncology", "metadata": {"intervention_id": 2773, "condition_id": 45490, "intervention_name": "Pralatrexate", "condition_name": "Gastrointestinal Tumours", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "val"} | |
| {"question_id": "CTL4-0292", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: methylprednisolone\nDrug type: small_molecule\nCondition: Non Invasive Ventilation (NIV)\nTherapeutic area: other", "metadata": {"intervention_id": 18, "condition_id": 31791, "intervention_name": "methylprednisolone", "condition_name": "Non Invasive Ventilation (NIV)", "molecular_type": "small_molecule", "therapeutic_area": "other"}, "untested_type": "trick", "split": "val"} | |
| {"question_id": "CTL4-0293", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: natalizumab\nDrug type: monoclonal_antibody\nCondition: Protection Against COVID-19 and Infections With SARS-CoV- 2\nTherapeutic area: infectious", "metadata": {"intervention_id": 5914, "condition_id": 43760, "intervention_name": "natalizumab", "condition_name": "Protection Against COVID-19 and Infections With SARS-CoV- 2", "molecular_type": "monoclonal_antibody", "therapeutic_area": "infectious"}, "untested_type": "obvious", "split": "val"} | |
| {"question_id": "CTL4-0294", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Bococizumab (PF-04950615;RN316)\nDrug type: monoclonal_antibody\nCondition: SLE (Systemic Lupus)\nTherapeutic area: autoimmune", "metadata": {"intervention_id": 4916, "condition_id": 1895, "intervention_name": "Bococizumab (PF-04950615;RN316)", "condition_name": "SLE (Systemic Lupus)", "molecular_type": "monoclonal_antibody", "therapeutic_area": "autoimmune"}, "untested_type": "obvious", "split": "val"} | |
| {"question_id": "CTL4-0295", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Rifaximin\nDrug type: small_molecule\nCondition: Low Bone Mass in Anorexia Nervosa Patients\nTherapeutic area: other", "metadata": {"intervention_id": 3018, "condition_id": 48526, "intervention_name": "Rifaximin", "condition_name": "Low Bone Mass in Anorexia Nervosa Patients", "molecular_type": "small_molecule", "therapeutic_area": "other"}, "untested_type": "trick", "split": "val"} | |
| {"question_id": "CTL4-0296", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Fludarabine\nDrug type: small_molecule\nCondition: Transthyretin-type Cardiac Amyloidosis\nTherapeutic area: cardiology", "metadata": {"intervention_id": 217, "condition_id": 915, "intervention_name": "Fludarabine", "condition_name": "Transthyretin-type Cardiac Amyloidosis", "molecular_type": "small_molecule", "therapeutic_area": "cardiology"}, "untested_type": "obvious", "split": "val"} | |
| {"question_id": "CTL4-0297", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Interleukin-2\nDrug type: peptide\nCondition: Contiguous Stage II Grade 3 Follicular Lymphoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 219, "condition_id": 1997, "intervention_name": "Interleukin-2", "condition_name": "Contiguous Stage II Grade 3 Follicular Lymphoma", "molecular_type": "peptide", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "val"} | |
| {"question_id": "CTL4-0298", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Valsartan/aliskiren\nCondition: FIGO Stage IIIA Ovarian Cancer\nTherapeutic area: oncology", "metadata": {"intervention_id": 861, "condition_id": 43874, "intervention_name": "Valsartan/aliskiren", "condition_name": "FIGO Stage IIIA Ovarian Cancer", "molecular_type": null, "therapeutic_area": "oncology"}, "untested_type": "obvious", "split": "val"} | |
| {"question_id": "CTL4-0299", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: savolitinib\nDrug type: small_molecule\nCondition: Relapsed Small Cell Lung Cancer (SCLC)\nTherapeutic area: oncology", "metadata": {"intervention_id": 6352, "condition_id": 29087, "intervention_name": "savolitinib", "condition_name": "Relapsed Small Cell Lung Cancer (SCLC)", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "val"} | |
| {"question_id": "CTL4-0300", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Isatuximab\nDrug type: monoclonal_antibody\nCondition: Heart Transplant Infection\nTherapeutic area: cardiology", "metadata": {"intervention_id": 365, "condition_id": 8782, "intervention_name": "Isatuximab", "condition_name": "Heart Transplant Infection", "molecular_type": "monoclonal_antibody", "therapeutic_area": "cardiology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0301", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Syntocinon\nDrug type: peptide\nCondition: Discoid Lupus Erthematosus of the Scalp\nTherapeutic area: autoimmune", "metadata": {"intervention_id": 3071, "condition_id": 55363, "intervention_name": "Syntocinon", "condition_name": "Discoid Lupus Erthematosus of the Scalp", "molecular_type": "peptide", "therapeutic_area": "autoimmune"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0302", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Humira\nDrug type: monoclonal_antibody\nCondition: Pre-diabetes\nTherapeutic area: metabolic", "metadata": {"intervention_id": 3935, "condition_id": 3663, "intervention_name": "Humira", "condition_name": "Pre-diabetes", "molecular_type": "monoclonal_antibody", "therapeutic_area": "metabolic"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0303", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: pazopanib hydrochloride\nDrug type: small_molecule\nCondition: Platinum-Resistant Ovarian Carcinoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 25478, "condition_id": 13026, "intervention_name": "pazopanib hydrochloride", "condition_name": "Platinum-Resistant Ovarian Carcinoma", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0304", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Vinblastine Sulfate\nDrug type: small_molecule\nCondition: Children With a Univentricular Heart Undergoing Surgery for Creation of a Fontan Circulation\nTherapeutic area: cardiology", "metadata": {"intervention_id": 124, "condition_id": 9026, "intervention_name": "Vinblastine Sulfate", "condition_name": "Children With a Univentricular Heart Undergoing Surgery for Creation of a Fontan Circulation", "molecular_type": "small_molecule", "therapeutic_area": "cardiology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0305", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Hyperthermic Intraperitoneal Chemotherapy\nCondition: KRAS Mutant Metastatic Colorectal Cancer\nTherapeutic area: oncology", "metadata": {"intervention_id": 13622, "condition_id": 54094, "intervention_name": "Hyperthermic Intraperitoneal Chemotherapy", "condition_name": "KRAS Mutant Metastatic Colorectal Cancer", "molecular_type": null, "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0306", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: ABI-H0731\nDrug type: small_molecule\nCondition: Chronic Laryngeal Neuropathy\nTherapeutic area: neurology", "metadata": {"intervention_id": 2453, "condition_id": 2706, "intervention_name": "ABI-H0731", "condition_name": "Chronic Laryngeal Neuropathy", "molecular_type": "small_molecule", "therapeutic_area": "neurology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0307", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: FLOT Chemotherapy\nCondition: Chronic Right-Sided Heart Failure\nTherapeutic area: cardiology", "metadata": {"intervention_id": 98, "condition_id": 48978, "intervention_name": "FLOT Chemotherapy", "condition_name": "Chronic Right-Sided Heart Failure", "molecular_type": null, "therapeutic_area": "cardiology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0308", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Trimetazidine\nDrug type: small_molecule\nCondition: Relapsed Acute Myelomonocytic Leukemia\nTherapeutic area: oncology", "metadata": {"intervention_id": 2205, "condition_id": 5913, "intervention_name": "Trimetazidine", "condition_name": "Relapsed Acute Myelomonocytic Leukemia", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0309", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Diazoxide\nDrug type: small_molecule\nCondition: System; Lupus Erythematosus\nTherapeutic area: autoimmune", "metadata": {"intervention_id": 4375, "condition_id": 52040, "intervention_name": "Diazoxide", "condition_name": "System; Lupus Erythematosus", "molecular_type": "small_molecule", "therapeutic_area": "autoimmune"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0310", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Semaglutide\nDrug type: peptide\nCondition: Mixed Guttate/Plaque Psoriasis\nTherapeutic area: autoimmune", "metadata": {"intervention_id": 170, "condition_id": 38975, "intervention_name": "Semaglutide", "condition_name": "Mixed Guttate/Plaque Psoriasis", "molecular_type": "peptide", "therapeutic_area": "autoimmune"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0311", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Dopamine\nDrug type: small_molecule\nCondition: Brain Neoplasm, Primary\nTherapeutic area: oncology", "metadata": {"intervention_id": 1478, "condition_id": 24427, "intervention_name": "Dopamine", "condition_name": "Brain Neoplasm, Primary", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0312", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Abiraterone Acetate\nDrug type: small_molecule\nCondition: Peritoneal Primary Cancer\nTherapeutic area: oncology", "metadata": {"intervention_id": 770, "condition_id": 41074, "intervention_name": "Abiraterone Acetate", "condition_name": "Peritoneal Primary Cancer", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0313", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: cemiplimab\nDrug type: monoclonal_antibody\nCondition: Recurrent Vaginal Carcinoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 1367, "condition_id": 49894, "intervention_name": "cemiplimab", "condition_name": "Recurrent Vaginal Carcinoma", "molecular_type": "monoclonal_antibody", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0314", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Irinotecan\nDrug type: small_molecule\nCondition: Mild Hypertension\nTherapeutic area: cardiology", "metadata": {"intervention_id": 241, "condition_id": 15496, "intervention_name": "Irinotecan", "condition_name": "Mild Hypertension", "molecular_type": "small_molecule", "therapeutic_area": "cardiology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0315", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Icodextrin\nDrug type: unknown\nCondition: DMMR Cancer\nTherapeutic area: oncology", "metadata": {"intervention_id": 2532, "condition_id": 12877, "intervention_name": "Icodextrin", "condition_name": "DMMR Cancer", "molecular_type": "unknown", "therapeutic_area": "oncology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0316", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Endotoxin\nCondition: Acute Pulmonary Embolism\nTherapeutic area: respiratory", "metadata": {"intervention_id": 10533, "condition_id": 12999, "intervention_name": "Endotoxin", "condition_name": "Acute Pulmonary Embolism", "molecular_type": null, "therapeutic_area": "respiratory"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0317", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Dupilumab\nDrug type: monoclonal_antibody\nCondition: Thyroid Nodule; Hyperthyroidism\nTherapeutic area: other", "metadata": {"intervention_id": 694, "condition_id": 41044, "intervention_name": "Dupilumab", "condition_name": "Thyroid Nodule; Hyperthyroidism", "molecular_type": "monoclonal_antibody", "therapeutic_area": "other"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0318", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: regadenoson\nDrug type: small_molecule\nCondition: Recurrent Mediastinal Lymphoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 2131, "condition_id": 49658, "intervention_name": "regadenoson", "condition_name": "Recurrent Mediastinal Lymphoma", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0319", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Rosuvastatin 20mg\nDrug type: small_molecule\nCondition: Necrotizing Enterocolitis of Newborn\nTherapeutic area: autoimmune", "metadata": {"intervention_id": 4490, "condition_id": 20713, "intervention_name": "Rosuvastatin 20mg", "condition_name": "Necrotizing Enterocolitis of Newborn", "molecular_type": "small_molecule", "therapeutic_area": "autoimmune"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0320", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Aspirin\nDrug type: small_molecule\nCondition: Vesicoureteral Reflux\nTherapeutic area: other", "metadata": {"intervention_id": 1441, "condition_id": 18536, "intervention_name": "Aspirin", "condition_name": "Vesicoureteral Reflux", "molecular_type": "small_molecule", "therapeutic_area": "other"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0321", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Dexmedetomidine group\nDrug type: small_molecule\nCondition: Brain (Nervous System) Cancers\nTherapeutic area: oncology", "metadata": {"intervention_id": 5477, "condition_id": 44018, "intervention_name": "Dexmedetomidine group", "condition_name": "Brain (Nervous System) Cancers", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0322", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: PDR001\nDrug type: monoclonal_antibody\nCondition: Rectal Cancer Recurrent\nTherapeutic area: oncology", "metadata": {"intervention_id": 7487, "condition_id": 22651, "intervention_name": "PDR001", "condition_name": "Rectal Cancer Recurrent", "molecular_type": "monoclonal_antibody", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0323", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Brentuximab Vedotin\nDrug type: antibody_drug_conjugate\nCondition: Acute Myeloid Leukemia With Maturation\nTherapeutic area: oncology", "metadata": {"intervention_id": 1720, "condition_id": 14993, "intervention_name": "Brentuximab Vedotin", "condition_name": "Acute Myeloid Leukemia With Maturation", "molecular_type": "antibody_drug_conjugate", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0324", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Vehicle twice daily\nCondition: Hyperlipidemia, Hypertriglyceridemia\nTherapeutic area: metabolic", "metadata": {"intervention_id": 1769, "condition_id": 29242, "intervention_name": "Vehicle twice daily", "condition_name": "Hyperlipidemia, Hypertriglyceridemia", "molecular_type": null, "therapeutic_area": "metabolic"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0325", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Dexamethasone\nDrug type: small_molecule\nCondition: Solid Tumor in Advanced Stage\nTherapeutic area: oncology", "metadata": {"intervention_id": 21, "condition_id": 14503, "intervention_name": "Dexamethasone", "condition_name": "Solid Tumor in Advanced Stage", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0326", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: nab-paclitaxel\nDrug type: small_molecule\nCondition: Esophagogastric Junction Cancers\nTherapeutic area: oncology", "metadata": {"intervention_id": 913, "condition_id": 55018, "intervention_name": "nab-paclitaxel", "condition_name": "Esophagogastric Junction Cancers", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0327", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: filgrastim\nDrug type: peptide\nCondition: Precapillary Pulmonary Hypertension\nTherapeutic area: cardiology", "metadata": {"intervention_id": 233, "condition_id": 20424, "intervention_name": "filgrastim", "condition_name": "Precapillary Pulmonary Hypertension", "molecular_type": "peptide", "therapeutic_area": "cardiology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0328", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Acetaminophen\nDrug type: small_molecule\nCondition: Odontalgia\nTherapeutic area: other", "metadata": {"intervention_id": 103, "condition_id": 15039, "intervention_name": "Acetaminophen", "condition_name": "Odontalgia", "molecular_type": "small_molecule", "therapeutic_area": "other"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0329", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: graft versus host disease prophylaxis/therapy\nCondition: Refractory Glioma\nTherapeutic area: oncology", "metadata": {"intervention_id": 4157, "condition_id": 7627, "intervention_name": "graft versus host disease prophylaxis/therapy", "condition_name": "Refractory Glioma", "molecular_type": null, "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0330", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Ondansetron\nDrug type: small_molecule\nCondition: Prediabetic\nTherapeutic area: other", "metadata": {"intervention_id": 2784, "condition_id": 10041, "intervention_name": "Ondansetron", "condition_name": "Prediabetic", "molecular_type": "small_molecule", "therapeutic_area": "other"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0331", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: anti-thymocyte globulin\nDrug type: other_biologic\nCondition: Rare CNS Tumor Recurrent\nTherapeutic area: oncology", "metadata": {"intervention_id": 739, "condition_id": 29188, "intervention_name": "anti-thymocyte globulin", "condition_name": "Rare CNS Tumor Recurrent", "molecular_type": "other_biologic", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0332", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: [123I] MNI-308\nCondition: Shivering, Spinal Anesthesia\nTherapeutic area: infectious", "metadata": {"intervention_id": 4285, "condition_id": 34818, "intervention_name": "[123I] MNI-308", "condition_name": "Shivering, Spinal Anesthesia", "molecular_type": null, "therapeutic_area": "infectious"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0333", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Dapagliflozin 5 mg\nDrug type: small_molecule\nCondition: Perianal Crohns'\nTherapeutic area: autoimmune", "metadata": {"intervention_id": 2371, "condition_id": 8018, "intervention_name": "Dapagliflozin 5 mg", "condition_name": "Perianal Crohns'", "molecular_type": "small_molecule", "therapeutic_area": "autoimmune"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0334", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Milrinone\nDrug type: small_molecule\nCondition: Grade II Neuroendocrine Carcinoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 4614, "condition_id": 39689, "intervention_name": "Milrinone", "condition_name": "Grade II Neuroendocrine Carcinoma", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0335", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: G-CSF\nDrug type: peptide\nCondition: Stage III Adrenal Cortical Carcinoma AJCC v7\nTherapeutic area: oncology", "metadata": {"intervention_id": 1705, "condition_id": 3295, "intervention_name": "G-CSF", "condition_name": "Stage III Adrenal Cortical Carcinoma AJCC v7", "molecular_type": "peptide", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0336", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Celecoxib\nDrug type: small_molecule\nCondition: Pulmonary Arterial Hypertension Related to Eisenmenger Physiology\nTherapeutic area: cardiology", "metadata": {"intervention_id": 345, "condition_id": 44765, "intervention_name": "Celecoxib", "condition_name": "Pulmonary Arterial Hypertension Related to Eisenmenger Physiology", "molecular_type": "small_molecule", "therapeutic_area": "cardiology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0337", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Pemigatinib\nDrug type: small_molecule\nCondition: Mesonephric Gynecologic Cancer\nTherapeutic area: oncology", "metadata": {"intervention_id": 9992, "condition_id": 39410, "intervention_name": "Pemigatinib", "condition_name": "Mesonephric Gynecologic Cancer", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0338", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Ribavirin\nDrug type: small_molecule\nCondition: Primary Parkinsonism\nTherapeutic area: neurology", "metadata": {"intervention_id": 285, "condition_id": 10040, "intervention_name": "Ribavirin", "condition_name": "Primary Parkinsonism", "molecular_type": "small_molecule", "therapeutic_area": "neurology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0339", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: goserelin acetate\nDrug type: peptide\nCondition: Idiopathic Intracranial Hypertension (IIH)\nTherapeutic area: cardiology", "metadata": {"intervention_id": 266, "condition_id": 14126, "intervention_name": "goserelin acetate", "condition_name": "Idiopathic Intracranial Hypertension (IIH)", "molecular_type": "peptide", "therapeutic_area": "cardiology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0340", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Dalteparin\nDrug type: other_biologic\nCondition: Superficial Venous Thrombosis of Leg, Secondary Prevention\nTherapeutic area: other", "metadata": {"intervention_id": 579, "condition_id": 13235, "intervention_name": "Dalteparin", "condition_name": "Superficial Venous Thrombosis of Leg, Secondary Prevention", "molecular_type": "other_biologic", "therapeutic_area": "other"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0341", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Daptomycin\nDrug type: small_molecule\nCondition: Dental and Gingival Conditions\nTherapeutic area: other", "metadata": {"intervention_id": 4329, "condition_id": 32214, "intervention_name": "Daptomycin", "condition_name": "Dental and Gingival Conditions", "molecular_type": "small_molecule", "therapeutic_area": "other"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0342", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Doxorubicin Hydrochloride\nDrug type: small_molecule\nCondition: Major Advanced Solid Tumors Other Than Colorectal\nTherapeutic area: oncology", "metadata": {"intervention_id": 119, "condition_id": 54946, "intervention_name": "Doxorubicin Hydrochloride", "condition_name": "Major Advanced Solid Tumors Other Than Colorectal", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0343", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Encorafenib\nDrug type: small_molecule\nCondition: Papillary Renal Cell Carcinoma Type 2\nTherapeutic area: oncology", "metadata": {"intervention_id": 13487, "condition_id": 14549, "intervention_name": "Encorafenib", "condition_name": "Papillary Renal Cell Carcinoma Type 2", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0344", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: imatinib mesylate\nDrug type: small_molecule\nCondition: Lymphoma in Leukemic Phase\nTherapeutic area: oncology", "metadata": {"intervention_id": 1336, "condition_id": 46448, "intervention_name": "imatinib mesylate", "condition_name": "Lymphoma in Leukemic Phase", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0345", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: SARS-CoV-2 mRNA Vaccine (CVnCoV)\nCondition: Peripheral (Sensorimotor) Diabetic Polyneuropathy\nTherapeutic area: neurology", "metadata": {"intervention_id": 307, "condition_id": 52946, "intervention_name": "SARS-CoV-2 mRNA Vaccine (CVnCoV)", "condition_name": "Peripheral (Sensorimotor) Diabetic Polyneuropathy", "molecular_type": null, "therapeutic_area": "neurology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0346", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: temsirolimus\nDrug type: small_molecule\nCondition: Stage IV Fallopian Tube Cancer AJCC v6 and v7\nTherapeutic area: oncology", "metadata": {"intervention_id": 2392, "condition_id": 8162, "intervention_name": "temsirolimus", "condition_name": "Stage IV Fallopian Tube Cancer AJCC v6 and v7", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0347", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Rucaparib\nDrug type: small_molecule\nCondition: Classical Hodgkin Lymphoma Recurrent\nTherapeutic area: oncology", "metadata": {"intervention_id": 580, "condition_id": 25631, "intervention_name": "Rucaparib", "condition_name": "Classical Hodgkin Lymphoma Recurrent", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0348", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Peginterferon Alfa-2a\nDrug type: peptide\nCondition: Nonepileptic Seizures\nTherapeutic area: neurology", "metadata": {"intervention_id": 284, "condition_id": 46702, "intervention_name": "Peginterferon Alfa-2a", "condition_name": "Nonepileptic Seizures", "molecular_type": "peptide", "therapeutic_area": "neurology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0349", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Tremelimumab\nDrug type: monoclonal_antibody\nCondition: Stage II Testicular Choriocarcinoma AJCC v6 and v7\nTherapeutic area: oncology", "metadata": {"intervention_id": 268, "condition_id": 31436, "intervention_name": "Tremelimumab", "condition_name": "Stage II Testicular Choriocarcinoma AJCC v6 and v7", "molecular_type": "monoclonal_antibody", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0350", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Pomalidomide\nDrug type: small_molecule\nCondition: Gastric Mucosa-Associated Lymphoid Tissue Lymphoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 1652, "condition_id": 17265, "intervention_name": "Pomalidomide", "condition_name": "Gastric Mucosa-Associated Lymphoid Tissue Lymphoma", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0351", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Vic-trastuzumab duocarmazine (SYD985) + paclitaxel\nCondition: Pro-Lymphocytic Leukemia\nTherapeutic area: oncology", "metadata": {"intervention_id": 98324, "condition_id": 53551, "intervention_name": "Vic-trastuzumab duocarmazine (SYD985) + paclitaxel", "condition_name": "Pro-Lymphocytic Leukemia", "molecular_type": null, "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0352", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Sirolimus\nDrug type: small_molecule\nCondition: Cardiac Surgery With Cardiopulmonary Bypass\nTherapeutic area: cardiology", "metadata": {"intervention_id": 55, "condition_id": 51830, "intervention_name": "Sirolimus", "condition_name": "Cardiac Surgery With Cardiopulmonary Bypass", "molecular_type": "small_molecule", "therapeutic_area": "cardiology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0353", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Dexchlorpheniramine\nDrug type: small_molecule\nCondition: H1N1 Influenza\nTherapeutic area: infectious", "metadata": {"intervention_id": 6948, "condition_id": 757, "intervention_name": "Dexchlorpheniramine", "condition_name": "H1N1 Influenza", "molecular_type": "small_molecule", "therapeutic_area": "infectious"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0354", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Plinabulin\nDrug type: small_molecule\nCondition: Digestive System Neoplasm\nTherapeutic area: oncology", "metadata": {"intervention_id": 19368, "condition_id": 29645, "intervention_name": "Plinabulin", "condition_name": "Digestive System Neoplasm", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0355", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Hydroxyurea\nDrug type: small_molecule\nCondition: Recurrent Malignant Extragonadal Non-Seminomatous Germ Cell Tumor\nTherapeutic area: oncology", "metadata": {"intervention_id": 2364, "condition_id": 15074, "intervention_name": "Hydroxyurea", "condition_name": "Recurrent Malignant Extragonadal Non-Seminomatous Germ Cell Tumor", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0356", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Sodium bicarbonate\nDrug type: small_molecule\nCondition: Gait Disorders in Old Age\nTherapeutic area: other", "metadata": {"intervention_id": 59, "condition_id": 11585, "intervention_name": "Sodium bicarbonate", "condition_name": "Gait Disorders in Old Age", "molecular_type": "small_molecule", "therapeutic_area": "other"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0357", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: oxaliplatin\nDrug type: small_molecule\nCondition: Atrial Fibrillation Recurrence\nTherapeutic area: cardiology", "metadata": {"intervention_id": 94, "condition_id": 46484, "intervention_name": "oxaliplatin", "condition_name": "Atrial Fibrillation Recurrence", "molecular_type": "small_molecule", "therapeutic_area": "cardiology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0358", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Ascorbic acid\nDrug type: small_molecule\nCondition: Recurrent Fallopian Tube Serous Adenocarcinoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 7095, "condition_id": 39053, "intervention_name": "Ascorbic acid", "condition_name": "Recurrent Fallopian Tube Serous Adenocarcinoma", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0359", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Ficlatuzumab\nDrug type: monoclonal_antibody\nCondition: Atrial Fibrillation Patients With Moderate or High Stroke Risk Who Had Undergone Catheter Ablation of Atrial Fibrillation\nTherapeutic area: cardiology", "metadata": {"intervention_id": 156, "condition_id": 36199, "intervention_name": "Ficlatuzumab", "condition_name": "Atrial Fibrillation Patients With Moderate or High Stroke Risk Who Had Undergone Catheter Ablation of Atrial Fibrillation", "molecular_type": "monoclonal_antibody", "therapeutic_area": "cardiology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0360", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Roflumilast\nDrug type: small_molecule\nCondition: Immersion Pulmonary Edema (IPE)\nTherapeutic area: respiratory", "metadata": {"intervention_id": 5762, "condition_id": 47329, "intervention_name": "Roflumilast", "condition_name": "Immersion Pulmonary Edema (IPE)", "molecular_type": "small_molecule", "therapeutic_area": "respiratory"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0361", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Rosuvastatin 10mg\nDrug type: small_molecule\nCondition: Familial Combined Hyperlipidemia\nTherapeutic area: metabolic", "metadata": {"intervention_id": 6854, "condition_id": 33191, "intervention_name": "Rosuvastatin 10mg", "condition_name": "Familial Combined Hyperlipidemia", "molecular_type": "small_molecule", "therapeutic_area": "metabolic"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0362", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Second blood sampling from left atrium\nCondition: Inoperable Hepatocellular Carcinoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 6057, "condition_id": 31595, "intervention_name": "Second blood sampling from left atrium", "condition_name": "Inoperable Hepatocellular Carcinoma", "molecular_type": null, "therapeutic_area": "oncology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0363", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Daivonex\nDrug type: small_molecule\nCondition: Haemodialyzed, Type 2 Diabetes\nTherapeutic area: metabolic", "metadata": {"intervention_id": 7833, "condition_id": 38777, "intervention_name": "Daivonex", "condition_name": "Haemodialyzed, Type 2 Diabetes", "molecular_type": "small_molecule", "therapeutic_area": "metabolic"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0364", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: fruquintinib\nDrug type: small_molecule\nCondition: Intracranial Hypertension\nTherapeutic area: cardiology", "metadata": {"intervention_id": 332, "condition_id": 21712, "intervention_name": "fruquintinib", "condition_name": "Intracranial Hypertension", "molecular_type": "small_molecule", "therapeutic_area": "cardiology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0365", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Alectinib\nDrug type: small_molecule\nCondition: Untreated Adult Acute Lymphoblastic Leukemia\nTherapeutic area: oncology", "metadata": {"intervention_id": 6274, "condition_id": 2621, "intervention_name": "Alectinib", "condition_name": "Untreated Adult Acute Lymphoblastic Leukemia", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0366", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Talazoparib\nDrug type: small_molecule\nCondition: Locally Advanced or Unresectable Metastatic Breast Cancer\nTherapeutic area: oncology", "metadata": {"intervention_id": 5755, "condition_id": 41876, "intervention_name": "Talazoparib", "condition_name": "Locally Advanced or Unresectable Metastatic Breast Cancer", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0367", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Naltrexone\nDrug type: small_molecule\nCondition: Vibrio Infections\nTherapeutic area: other", "metadata": {"intervention_id": 3963, "condition_id": 16153, "intervention_name": "Naltrexone", "condition_name": "Vibrio Infections", "molecular_type": "small_molecule", "therapeutic_area": "other"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0368", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: pemetrexed disodium\nDrug type: small_molecule\nCondition: Leukemia, T-Cell Large Granular Lymphocytic\nTherapeutic area: oncology", "metadata": {"intervention_id": 18614, "condition_id": 39588, "intervention_name": "pemetrexed disodium", "condition_name": "Leukemia, T-Cell Large Granular Lymphocytic", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0369", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Pertuzumab\nDrug type: monoclonal_antibody\nCondition: Relapsed/Refractory Hairy Cell Leukemia\nTherapeutic area: oncology", "metadata": {"intervention_id": 2490, "condition_id": 16677, "intervention_name": "Pertuzumab", "condition_name": "Relapsed/Refractory Hairy Cell Leukemia", "molecular_type": "monoclonal_antibody", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0370", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: 5-fluorouracil\nDrug type: small_molecule\nCondition: Primum Atrial Septal Defect\nTherapeutic area: cardiology", "metadata": {"intervention_id": 29, "condition_id": 32331, "intervention_name": "5-fluorouracil", "condition_name": "Primum Atrial Septal Defect", "molecular_type": "small_molecule", "therapeutic_area": "cardiology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0371", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: becatecarin\nDrug type: small_molecule\nCondition: Cardiac Transplantation\nTherapeutic area: cardiology", "metadata": {"intervention_id": 93, "condition_id": 9787, "intervention_name": "becatecarin", "condition_name": "Cardiac Transplantation", "molecular_type": "small_molecule", "therapeutic_area": "cardiology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0372", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Luvadaxistat\nDrug type: small_molecule\nCondition: Chronic Obstructive Pulmonary Disease With (Acute) Exacerbation\nTherapeutic area: respiratory", "metadata": {"intervention_id": 5023, "condition_id": 49990, "intervention_name": "Luvadaxistat", "condition_name": "Chronic Obstructive Pulmonary Disease With (Acute) Exacerbation", "molecular_type": "small_molecule", "therapeutic_area": "respiratory"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0373", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Sodium Thiosulfate\nDrug type: small_molecule\nCondition: Therapy-Related Myeloid Neoplasm\nTherapeutic area: oncology", "metadata": {"intervention_id": 4106, "condition_id": 44619, "intervention_name": "Sodium Thiosulfate", "condition_name": "Therapy-Related Myeloid Neoplasm", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0374", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Mifepristone\nDrug type: small_molecule\nCondition: Accidental Exposure While Preparing Drug for Administration\nTherapeutic area: other", "metadata": {"intervention_id": 944, "condition_id": 30545, "intervention_name": "Mifepristone", "condition_name": "Accidental Exposure While Preparing Drug for Administration", "molecular_type": "small_molecule", "therapeutic_area": "other"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0375", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: montelukast sodium\nDrug type: small_molecule\nCondition: Gliomas Harboring IDH1 and/or IDH2 Mutations\nTherapeutic area: oncology", "metadata": {"intervention_id": 906, "condition_id": 46137, "intervention_name": "montelukast sodium", "condition_name": "Gliomas Harboring IDH1 and/or IDH2 Mutations", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0376", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: LY3202626\nDrug type: unknown\nCondition: Post COVID-19\nTherapeutic area: infectious", "metadata": {"intervention_id": 574, "condition_id": 30429, "intervention_name": "LY3202626", "condition_name": "Post COVID-19", "molecular_type": "unknown", "therapeutic_area": "infectious"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0377", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Ganetespib\nDrug type: small_molecule\nCondition: Lymphomatoid Granulomatosis\nTherapeutic area: oncology", "metadata": {"intervention_id": 22104, "condition_id": 43893, "intervention_name": "Ganetespib", "condition_name": "Lymphomatoid Granulomatosis", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0378", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Thymoglobulin\nDrug type: other_biologic\nCondition: Buccal Mucosa Squamous Cell Carcinoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 20645, "condition_id": 55572, "intervention_name": "Thymoglobulin", "condition_name": "Buccal Mucosa Squamous Cell Carcinoma", "molecular_type": "other_biologic", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0379", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Enalapril\nDrug type: small_molecule\nCondition: Planned Elective Cardiac Surgery Using CPB\nTherapeutic area: cardiology", "metadata": {"intervention_id": 9946, "condition_id": 46925, "intervention_name": "Enalapril", "condition_name": "Planned Elective Cardiac Surgery Using CPB", "molecular_type": "small_molecule", "therapeutic_area": "cardiology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0380", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Azilsartan medoxomil and chlorthalidone\nCondition: Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8\nTherapeutic area: oncology", "metadata": {"intervention_id": 3593, "condition_id": 34002, "intervention_name": "Azilsartan medoxomil and chlorthalidone", "condition_name": "Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8", "molecular_type": null, "therapeutic_area": "oncology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0381", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Tremelimumab\nDrug type: monoclonal_antibody\nCondition: Ventricular Thrombosis Mural Following Myocardial Infarction\nTherapeutic area: cardiology", "metadata": {"intervention_id": 268, "condition_id": 35294, "intervention_name": "Tremelimumab", "condition_name": "Ventricular Thrombosis Mural Following Myocardial Infarction", "molecular_type": "monoclonal_antibody", "therapeutic_area": "cardiology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0382", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Mitoxantrone\nDrug type: small_molecule\nCondition: Myelodysplastic/Myeloproliferative Neoplasm Overlap Syndrome\nTherapeutic area: oncology", "metadata": {"intervention_id": 7112, "condition_id": 30890, "intervention_name": "Mitoxantrone", "condition_name": "Myelodysplastic/Myeloproliferative Neoplasm Overlap Syndrome", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0383", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Nipocalimab\nDrug type: monoclonal_antibody\nCondition: Persistent Proteinuria With Type II Diabetes\nTherapeutic area: metabolic", "metadata": {"intervention_id": 3021, "condition_id": 44577, "intervention_name": "Nipocalimab", "condition_name": "Persistent Proteinuria With Type II Diabetes", "molecular_type": "monoclonal_antibody", "therapeutic_area": "metabolic"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0384", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Rivastigmine\nDrug type: small_molecule\nCondition: HIV Infection Associated Kaposi Disease\nTherapeutic area: infectious", "metadata": {"intervention_id": 952, "condition_id": 51042, "intervention_name": "Rivastigmine", "condition_name": "HIV Infection Associated Kaposi Disease", "molecular_type": "small_molecule", "therapeutic_area": "infectious"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0385", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Ranolazine\nDrug type: small_molecule\nCondition: Non-Cardiac Chest Pain\nTherapeutic area: cardiology", "metadata": {"intervention_id": 6531, "condition_id": 55166, "intervention_name": "Ranolazine", "condition_name": "Non-Cardiac Chest Pain", "molecular_type": "small_molecule", "therapeutic_area": "cardiology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0386", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Labetalol\nDrug type: small_molecule\nCondition: Recurrent Nasal Cavity Squamous Cell Carcinoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 5254, "condition_id": 39218, "intervention_name": "Labetalol", "condition_name": "Recurrent Nasal Cavity Squamous Cell Carcinoma", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0387", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Entinostat\nDrug type: small_molecule\nCondition: Carcinoma, Small Cell Lung\nTherapeutic area: oncology", "metadata": {"intervention_id": 1495, "condition_id": 4417, "intervention_name": "Entinostat", "condition_name": "Carcinoma, Small Cell Lung", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0388", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Erlotinib\nDrug type: small_molecule\nCondition: Muscle-invasive Urothelial Carcinoma of the Bladder\nTherapeutic area: oncology", "metadata": {"intervention_id": 157, "condition_id": 21723, "intervention_name": "Erlotinib", "condition_name": "Muscle-invasive Urothelial Carcinoma of the Bladder", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0389", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Atezolizumab\nDrug type: monoclonal_antibody\nCondition: Soft Tissue Sarcoma of the Extremity\nTherapeutic area: oncology", "metadata": {"intervention_id": 1333, "condition_id": 48342, "intervention_name": "Atezolizumab", "condition_name": "Soft Tissue Sarcoma of the Extremity", "molecular_type": "monoclonal_antibody", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0390", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Trastuzumab\nDrug type: monoclonal_antibody\nCondition: Part 2 - Patients With Hypertension\nTherapeutic area: cardiology", "metadata": {"intervention_id": 209, "condition_id": 12105, "intervention_name": "Trastuzumab", "condition_name": "Part 2 - Patients With Hypertension", "molecular_type": "monoclonal_antibody", "therapeutic_area": "cardiology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0391", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Tc99m-Maraciclatide\nCondition: Pathologic Stage IV Gastric Cancer AJCC v8\nTherapeutic area: oncology", "metadata": {"intervention_id": 4115, "condition_id": 15506, "intervention_name": "Tc99m-Maraciclatide", "condition_name": "Pathologic Stage IV Gastric Cancer AJCC v8", "molecular_type": null, "therapeutic_area": "oncology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0392", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Avelumab\nDrug type: monoclonal_antibody\nCondition: Vulnerable Coronary Plaques\nTherapeutic area: cardiology", "metadata": {"intervention_id": 294, "condition_id": 20649, "intervention_name": "Avelumab", "condition_name": "Vulnerable Coronary Plaques", "molecular_type": "monoclonal_antibody", "therapeutic_area": "cardiology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0393", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Daratumumab\nDrug type: monoclonal_antibody\nCondition: Adenocarcinoma of Biliary Tract\nTherapeutic area: oncology", "metadata": {"intervention_id": 2055, "condition_id": 42722, "intervention_name": "Daratumumab", "condition_name": "Adenocarcinoma of Biliary Tract", "molecular_type": "monoclonal_antibody", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0394", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Cutaneous Cream application\nCondition: Cardiac Edema\nTherapeutic area: cardiology", "metadata": {"intervention_id": 280, "condition_id": 8056, "intervention_name": "Cutaneous Cream application", "condition_name": "Cardiac Edema", "molecular_type": null, "therapeutic_area": "cardiology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0395", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Azacitidine\nDrug type: small_molecule\nCondition: The Elderly (≥ 70 Years) With Essential Hypertension\nTherapeutic area: cardiology", "metadata": {"intervention_id": 295, "condition_id": 49535, "intervention_name": "Azacitidine", "condition_name": "The Elderly (≥ 70 Years) With Essential Hypertension", "molecular_type": "small_molecule", "therapeutic_area": "cardiology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0396", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: SRT2104\nDrug type: small_molecule\nCondition: Crohn's Disease and Ulcerative Colitis\nTherapeutic area: autoimmune", "metadata": {"intervention_id": 4674, "condition_id": 35559, "intervention_name": "SRT2104", "condition_name": "Crohn's Disease and Ulcerative Colitis", "molecular_type": "small_molecule", "therapeutic_area": "autoimmune"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0397", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Recombinant COVID-19 vaccine (Sf9 cells)\nCondition: Epilepsy, Simple Partial\nTherapeutic area: neurology", "metadata": {"intervention_id": 1399, "condition_id": 6150, "intervention_name": "Recombinant COVID-19 vaccine (Sf9 cells)", "condition_name": "Epilepsy, Simple Partial", "molecular_type": null, "therapeutic_area": "neurology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0398", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Obinutuzumab\nDrug type: monoclonal_antibody\nCondition: Cancer Induced Bone Pain\nTherapeutic area: oncology", "metadata": {"intervention_id": 2255, "condition_id": 50539, "intervention_name": "Obinutuzumab", "condition_name": "Cancer Induced Bone Pain", "molecular_type": "monoclonal_antibody", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0399", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Lu AG06466\nCondition: Multi Drug Resistant Tuberculosis\nTherapeutic area: infectious", "metadata": {"intervention_id": 1023, "condition_id": 9773, "intervention_name": "Lu AG06466", "condition_name": "Multi Drug Resistant Tuberculosis", "molecular_type": null, "therapeutic_area": "infectious"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0400", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Bintrafusp Alfa\nDrug type: peptide\nCondition: Nodal Peripheral T-Cell Lymphoma With TFH Phenotype\nTherapeutic area: oncology", "metadata": {"intervention_id": 9538, "condition_id": 5995, "intervention_name": "Bintrafusp Alfa", "condition_name": "Nodal Peripheral T-Cell Lymphoma With TFH Phenotype", "molecular_type": "peptide", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0401", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: ferumoxytol\nDrug type: unknown\nCondition: B-cell Non Hodgkin Lymphoma (NHL)\nTherapeutic area: oncology", "metadata": {"intervention_id": 12221, "condition_id": 35167, "intervention_name": "ferumoxytol", "condition_name": "B-cell Non Hodgkin Lymphoma (NHL)", "molecular_type": "unknown", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0402", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Canagliflozin 100 mg\nCondition: Stage IVC Oral Cavity Cancer AJCC v6 and v7\nTherapeutic area: oncology", "metadata": {"intervention_id": 3298, "condition_id": 24408, "intervention_name": "Canagliflozin 100 mg", "condition_name": "Stage IVC Oral Cavity Cancer AJCC v6 and v7", "molecular_type": null, "therapeutic_area": "oncology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0403", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Hydrocortisone\nDrug type: small_molecule\nCondition: Cancer Of The Extrahepatic Bile Duct\nTherapeutic area: oncology", "metadata": {"intervention_id": 992, "condition_id": 17011, "intervention_name": "Hydrocortisone", "condition_name": "Cancer Of The Extrahepatic Bile Duct", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0404", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Rimiducid\nDrug type: small_molecule\nCondition: Stage IIB Lung Cancer AJCC v8\nTherapeutic area: oncology", "metadata": {"intervention_id": 1982, "condition_id": 16520, "intervention_name": "Rimiducid", "condition_name": "Stage IIB Lung Cancer AJCC v8", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0405", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Methylphenidate\nDrug type: small_molecule\nCondition: Bleeding and Cardiac Surgery\nTherapeutic area: cardiology", "metadata": {"intervention_id": 347, "condition_id": 18068, "intervention_name": "Methylphenidate", "condition_name": "Bleeding and Cardiac Surgery", "molecular_type": "small_molecule", "therapeutic_area": "cardiology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0406", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Simvastatin\nDrug type: small_molecule\nCondition: NGAL\nTherapeutic area: other", "metadata": {"intervention_id": 1666, "condition_id": 41359, "intervention_name": "Simvastatin", "condition_name": "NGAL", "molecular_type": "small_molecule", "therapeutic_area": "other"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0407", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: emtricitabine/tenofovir + lopinavir/ritonavir (WHO recommended second line)\nCondition: Family History of Dementia\nTherapeutic area: neurology", "metadata": {"intervention_id": 1316, "condition_id": 22171, "intervention_name": "emtricitabine/tenofovir + lopinavir/ritonavir (WHO recommended second line)", "condition_name": "Family History of Dementia", "molecular_type": null, "therapeutic_area": "neurology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0408", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Afamelanotide\nDrug type: peptide\nCondition: Human Immunodeficiency Virus (HIV) Prophylaxis\nTherapeutic area: infectious", "metadata": {"intervention_id": 2922, "condition_id": 45654, "intervention_name": "Afamelanotide", "condition_name": "Human Immunodeficiency Virus (HIV) Prophylaxis", "molecular_type": "peptide", "therapeutic_area": "infectious"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0409", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Naproxen\nDrug type: small_molecule\nCondition: Chronic Ulcer of Lower Extremity\nTherapeutic area: other", "metadata": {"intervention_id": 383, "condition_id": 31365, "intervention_name": "Naproxen", "condition_name": "Chronic Ulcer of Lower Extremity", "molecular_type": "small_molecule", "therapeutic_area": "other"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0410", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Moxifloxacin\nDrug type: small_molecule\nCondition: Sjogren's Syndrome (SS)\nTherapeutic area: other", "metadata": {"intervention_id": 116, "condition_id": 51779, "intervention_name": "Moxifloxacin", "condition_name": "Sjogren's Syndrome (SS)", "molecular_type": "small_molecule", "therapeutic_area": "other"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0411", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Ethambutol\nDrug type: small_molecule\nCondition: Frontal Lobe Dementia\nTherapeutic area: neurology", "metadata": {"intervention_id": 2041, "condition_id": 33122, "intervention_name": "Ethambutol", "condition_name": "Frontal Lobe Dementia", "molecular_type": "small_molecule", "therapeutic_area": "neurology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0412", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Nanrilkefusp Alfa\nDrug type: peptide\nCondition: DLBCL Transformed From Indolent Lymphoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 61110, "condition_id": 20944, "intervention_name": "Nanrilkefusp Alfa", "condition_name": "DLBCL Transformed From Indolent Lymphoma", "molecular_type": "peptide", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0413", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: tranexamic acid\nDrug type: small_molecule\nCondition: Childhood NHL\nTherapeutic area: other", "metadata": {"intervention_id": 447, "condition_id": 21058, "intervention_name": "tranexamic acid", "condition_name": "Childhood NHL", "molecular_type": "small_molecule", "therapeutic_area": "other"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0414", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Creatine\nDrug type: small_molecule\nCondition: Autoimmune Chronic Hepatitis\nTherapeutic area: infectious", "metadata": {"intervention_id": 5940, "condition_id": 33011, "intervention_name": "Creatine", "condition_name": "Autoimmune Chronic Hepatitis", "molecular_type": "small_molecule", "therapeutic_area": "infectious"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0415", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: First blood sampling from left atrium\nCondition: Stage IV Anal Canal Cancer\nTherapeutic area: oncology", "metadata": {"intervention_id": 6055, "condition_id": 55912, "intervention_name": "First blood sampling from left atrium", "condition_name": "Stage IV Anal Canal Cancer", "molecular_type": null, "therapeutic_area": "oncology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0416", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Spartalizumab\nDrug type: monoclonal_antibody\nCondition: Non-Small Cell Lung Cancer, Colorectal Cancer, Renal Cell Carcinoma, Melanoma and Other Solid Tumor\nTherapeutic area: oncology", "metadata": {"intervention_id": 6907, "condition_id": 32803, "intervention_name": "Spartalizumab", "condition_name": "Non-Small Cell Lung Cancer, Colorectal Cancer, Renal Cell Carcinoma, Melanoma and Other Solid Tumor", "molecular_type": "monoclonal_antibody", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0417", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: cilengitide\nDrug type: peptide\nCondition: Microvascular Coronary Artery Disease\nTherapeutic area: cardiology", "metadata": {"intervention_id": 137, "condition_id": 7600, "intervention_name": "cilengitide", "condition_name": "Microvascular Coronary Artery Disease", "molecular_type": "peptide", "therapeutic_area": "cardiology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0418", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Tricaprilin\nDrug type: small_molecule\nCondition: Influenza-like Illness\nTherapeutic area: infectious", "metadata": {"intervention_id": 4671, "condition_id": 1175, "intervention_name": "Tricaprilin", "condition_name": "Influenza-like Illness", "molecular_type": "small_molecule", "therapeutic_area": "infectious"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0419", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Haloperidol\nDrug type: small_molecule\nCondition: Oocyte Retrieval\nTherapeutic area: other", "metadata": {"intervention_id": 3036, "condition_id": 17432, "intervention_name": "Haloperidol", "condition_name": "Oocyte Retrieval", "molecular_type": "small_molecule", "therapeutic_area": "other"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0420", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Secukinumab\nDrug type: monoclonal_antibody\nCondition: Primary Sjogren Syndrome\nTherapeutic area: other", "metadata": {"intervention_id": 1006, "condition_id": 25191, "intervention_name": "Secukinumab", "condition_name": "Primary Sjogren Syndrome", "molecular_type": "monoclonal_antibody", "therapeutic_area": "other"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0421", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: carmustine\nDrug type: small_molecule\nCondition: Neoplasms, Connective Tissue\nTherapeutic area: oncology", "metadata": {"intervention_id": 1195, "condition_id": 8542, "intervention_name": "carmustine", "condition_name": "Neoplasms, Connective Tissue", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0422", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: temozolomide\nDrug type: small_molecule\nCondition: Right Sided Heart Failure With Normal Ejection Fraction\nTherapeutic area: cardiology", "metadata": {"intervention_id": 138, "condition_id": 43566, "intervention_name": "temozolomide", "condition_name": "Right Sided Heart Failure With Normal Ejection Fraction", "molecular_type": "small_molecule", "therapeutic_area": "cardiology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0423", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Dulaglutide\nDrug type: peptide\nCondition: Clostridium Enterocolitis\nTherapeutic area: autoimmune", "metadata": {"intervention_id": 1077, "condition_id": 2923, "intervention_name": "Dulaglutide", "condition_name": "Clostridium Enterocolitis", "molecular_type": "peptide", "therapeutic_area": "autoimmune"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0424", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: ACTH\nDrug type: unknown\nCondition: Hepatitis\nTherapeutic area: infectious", "metadata": {"intervention_id": 3313, "condition_id": 9937, "intervention_name": "ACTH", "condition_name": "Hepatitis", "molecular_type": "unknown", "therapeutic_area": "infectious"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0425", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Fasiglifam\nDrug type: small_molecule\nCondition: Moderate Active Ulcerative Colitis\nTherapeutic area: autoimmune", "metadata": {"intervention_id": 1691, "condition_id": 21645, "intervention_name": "Fasiglifam", "condition_name": "Moderate Active Ulcerative Colitis", "molecular_type": "small_molecule", "therapeutic_area": "autoimmune"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0426", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Linezolid\nDrug type: small_molecule\nCondition: Acute Moderate-to-severe Pain\nTherapeutic area: other", "metadata": {"intervention_id": 2409, "condition_id": 44360, "intervention_name": "Linezolid", "condition_name": "Acute Moderate-to-severe Pain", "molecular_type": "small_molecule", "therapeutic_area": "other"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0427", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Immediate release torsemide 20mg tablet\nCondition: Stage IIIA Endometrial Carcinoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 2557, "condition_id": 30245, "intervention_name": "Immediate release torsemide 20mg tablet", "condition_name": "Stage IIIA Endometrial Carcinoma", "molecular_type": null, "therapeutic_area": "oncology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0428", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Intravenous (IV) SEA-CD40\nCondition: Refractory Mucosa-Associated Lymphoid Tissue Lymphoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 118840, "condition_id": 35192, "intervention_name": "Intravenous (IV) SEA-CD40", "condition_name": "Refractory Mucosa-Associated Lymphoid Tissue Lymphoma", "molecular_type": null, "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0429", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Sapanisertib\nDrug type: small_molecule\nCondition: Metastatic Cancers\nTherapeutic area: oncology", "metadata": {"intervention_id": 835, "condition_id": 4379, "intervention_name": "Sapanisertib", "condition_name": "Metastatic Cancers", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0430", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Efavirenz (EFV)\nDrug type: small_molecule\nCondition: Tuberous Sclerosis Complex-associated Refractory Seizures\nTherapeutic area: neurology", "metadata": {"intervention_id": 1015, "condition_id": 39756, "intervention_name": "Efavirenz (EFV)", "condition_name": "Tuberous Sclerosis Complex-associated Refractory Seizures", "molecular_type": "small_molecule", "therapeutic_area": "neurology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0431", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: rivogenlecleucel\nDrug type: cell_therapy\nCondition: Inoperable Locally Advanced or Metastatic Biliary Tract Cancer\nTherapeutic area: oncology", "metadata": {"intervention_id": 27133, "condition_id": 18207, "intervention_name": "rivogenlecleucel", "condition_name": "Inoperable Locally Advanced or Metastatic Biliary Tract Cancer", "molecular_type": "cell_therapy", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0432", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: GW856553\nDrug type: small_molecule\nCondition: Recurrent Malignant Solid Neoplasm\nTherapeutic area: oncology", "metadata": {"intervention_id": 2481, "condition_id": 5343, "intervention_name": "GW856553", "condition_name": "Recurrent Malignant Solid Neoplasm", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0433", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Aripiprazole\nDrug type: small_molecule\nCondition: Envenomation, Snake\nTherapeutic area: other", "metadata": {"intervention_id": 628, "condition_id": 23497, "intervention_name": "Aripiprazole", "condition_name": "Envenomation, Snake", "molecular_type": "small_molecule", "therapeutic_area": "other"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0434", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Bendamustine Hydrochloride\nDrug type: small_molecule\nCondition: Osteosarcoma Recurrent\nTherapeutic area: oncology", "metadata": {"intervention_id": 9393, "condition_id": 30494, "intervention_name": "Bendamustine Hydrochloride", "condition_name": "Osteosarcoma Recurrent", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0435", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: adavosertib\nDrug type: small_molecule\nCondition: Local Neoplasm Recurrence\nTherapeutic area: oncology", "metadata": {"intervention_id": 10408, "condition_id": 41362, "intervention_name": "adavosertib", "condition_name": "Local Neoplasm Recurrence", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0436", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Met IR\nDrug type: small_molecule\nCondition: Systemic Lupus Erythematosus (Disorder)\nTherapeutic area: autoimmune", "metadata": {"intervention_id": 2693, "condition_id": 36827, "intervention_name": "Met IR", "condition_name": "Systemic Lupus Erythematosus (Disorder)", "molecular_type": "small_molecule", "therapeutic_area": "autoimmune"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0437", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Bradykinin\nDrug type: peptide\nCondition: Pustular; Psoriasis, Palmaris Et Plantaris\nTherapeutic area: autoimmune", "metadata": {"intervention_id": 2407, "condition_id": 50959, "intervention_name": "Bradykinin", "condition_name": "Pustular; Psoriasis, Palmaris Et Plantaris", "molecular_type": "peptide", "therapeutic_area": "autoimmune"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0438", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Oxygen\nDrug type: small_molecule\nCondition: Lacrimal Apparatus Disease\nTherapeutic area: other", "metadata": {"intervention_id": 2236, "condition_id": 42366, "intervention_name": "Oxygen", "condition_name": "Lacrimal Apparatus Disease", "molecular_type": "small_molecule", "therapeutic_area": "other"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0439", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: ritonavir\nDrug type: small_molecule\nCondition: Acute Myocarditis\nTherapeutic area: other", "metadata": {"intervention_id": 2174, "condition_id": 30811, "intervention_name": "ritonavir", "condition_name": "Acute Myocarditis", "molecular_type": "small_molecule", "therapeutic_area": "other"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0440", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Duloxetine\nDrug type: small_molecule\nCondition: Anti-Bacterial Agents\nTherapeutic area: other", "metadata": {"intervention_id": 1002, "condition_id": 11466, "intervention_name": "Duloxetine", "condition_name": "Anti-Bacterial Agents", "molecular_type": "small_molecule", "therapeutic_area": "other"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0441", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: oxaliplatin\nDrug type: small_molecule\nCondition: Recurrent Acute Undifferentiated Leukemia\nTherapeutic area: oncology", "metadata": {"intervention_id": 94, "condition_id": 35503, "intervention_name": "oxaliplatin", "condition_name": "Recurrent Acute Undifferentiated Leukemia", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0442", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Pyrazinamide\nDrug type: small_molecule\nCondition: Benign Childhood Epilepsy With Centrotemporal Spikes\nTherapeutic area: neurology", "metadata": {"intervention_id": 2037, "condition_id": 48158, "intervention_name": "Pyrazinamide", "condition_name": "Benign Childhood Epilepsy With Centrotemporal Spikes", "molecular_type": "small_molecule", "therapeutic_area": "neurology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0443", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Cetuximab\nDrug type: monoclonal_antibody\nCondition: Atheroma; Myocardial\nTherapeutic area: cardiology", "metadata": {"intervention_id": 208, "condition_id": 53539, "intervention_name": "Cetuximab", "condition_name": "Atheroma; Myocardial", "molecular_type": "monoclonal_antibody", "therapeutic_area": "cardiology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0444", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Pacritinib\nDrug type: small_molecule\nCondition: Nervous System Tumor\nTherapeutic area: oncology", "metadata": {"intervention_id": 7310, "condition_id": 40465, "intervention_name": "Pacritinib", "condition_name": "Nervous System Tumor", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0445", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: (S)-Propafenone\nDrug type: small_molecule\nCondition: Platinum-Resistant Urothelial Carcinoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 5352, "condition_id": 12980, "intervention_name": "(S)-Propafenone", "condition_name": "Platinum-Resistant Urothelial Carcinoma", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0446", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Doxycycline\nDrug type: small_molecule\nCondition: Pediatric Adenotonsillectomy\nTherapeutic area: other", "metadata": {"intervention_id": 841, "condition_id": 53096, "intervention_name": "Doxycycline", "condition_name": "Pediatric Adenotonsillectomy", "molecular_type": "small_molecule", "therapeutic_area": "other"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0447", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Delamanid\nDrug type: small_molecule\nCondition: Exertional Heat Stroke\nTherapeutic area: neurology", "metadata": {"intervention_id": 2038, "condition_id": 51966, "intervention_name": "Delamanid", "condition_name": "Exertional Heat Stroke", "molecular_type": "small_molecule", "therapeutic_area": "neurology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0448", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Pemetrexed\nDrug type: small_molecule\nCondition: Valve Disease, Heart\nTherapeutic area: cardiology", "metadata": {"intervention_id": 147, "condition_id": 30624, "intervention_name": "Pemetrexed", "condition_name": "Valve Disease, Heart", "molecular_type": "small_molecule", "therapeutic_area": "cardiology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0449", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Maraviroc\nDrug type: small_molecule\nCondition: Epilepsy With Partial On-set Seizures\nTherapeutic area: neurology", "metadata": {"intervention_id": 191, "condition_id": 29853, "intervention_name": "Maraviroc", "condition_name": "Epilepsy With Partial On-set Seizures", "molecular_type": "small_molecule", "therapeutic_area": "neurology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0450", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: LY2409021\nDrug type: small_molecule\nCondition: Enterocolitis, Necrotizing\nTherapeutic area: autoimmune", "metadata": {"intervention_id": 1100, "condition_id": 36804, "intervention_name": "LY2409021", "condition_name": "Enterocolitis, Necrotizing", "molecular_type": "small_molecule", "therapeutic_area": "autoimmune"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0451", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Enoxaparin\nDrug type: other_biologic\nCondition: Renal Dialysis / Methods\nTherapeutic area: other", "metadata": {"intervention_id": 1536, "condition_id": 33651, "intervention_name": "Enoxaparin", "condition_name": "Renal Dialysis / Methods", "molecular_type": "other_biologic", "therapeutic_area": "other"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0452", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Erlotinib Hydrochloride\nDrug type: small_molecule\nCondition: Stage 0 Breast Carcinoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 1856, "condition_id": 16917, "intervention_name": "Erlotinib Hydrochloride", "condition_name": "Stage 0 Breast Carcinoma", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0453", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Vehicle\nDrug type: unknown\nCondition: Post-exposure Prophylaxis\nTherapeutic area: other", "metadata": {"intervention_id": 777, "condition_id": 11729, "intervention_name": "Vehicle", "condition_name": "Post-exposure Prophylaxis", "molecular_type": "unknown", "therapeutic_area": "other"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0454", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: bortezomib\nDrug type: small_molecule\nCondition: Eye Cancer\nTherapeutic area: oncology", "metadata": {"intervention_id": 1646, "condition_id": 38128, "intervention_name": "bortezomib", "condition_name": "Eye Cancer", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0455", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: PF06263276\nCondition: Chronic Kidney Disease Due to Type 2 Diabetes Mellitus\nTherapeutic area: metabolic", "metadata": {"intervention_id": 7831, "condition_id": 14365, "intervention_name": "PF06263276", "condition_name": "Chronic Kidney Disease Due to Type 2 Diabetes Mellitus", "molecular_type": null, "therapeutic_area": "metabolic"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0456", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Blood sampling from the femoral vein\nCondition: Stage IVB Pharyngeal Cancer\nTherapeutic area: oncology", "metadata": {"intervention_id": 6054, "condition_id": 17363, "intervention_name": "Blood sampling from the femoral vein", "condition_name": "Stage IVB Pharyngeal Cancer", "molecular_type": null, "therapeutic_area": "oncology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0457", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Influenza Virus Vaccine Inactivated\nCondition: Simple Partial Seizures\nTherapeutic area: neurology", "metadata": {"intervention_id": 2264, "condition_id": 16954, "intervention_name": "Influenza Virus Vaccine Inactivated", "condition_name": "Simple Partial Seizures", "molecular_type": null, "therapeutic_area": "neurology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0458", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Eslicarbazepine acetate\nDrug type: small_molecule\nCondition: Viral Hepatitis\nTherapeutic area: infectious", "metadata": {"intervention_id": 3472, "condition_id": 14003, "intervention_name": "Eslicarbazepine acetate", "condition_name": "Viral Hepatitis", "molecular_type": "small_molecule", "therapeutic_area": "infectious"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0459", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Lithium or Valproate with Aripiprazole\nCondition: Pulmonary Emphysema\nTherapeutic area: respiratory", "metadata": {"intervention_id": 17664, "condition_id": 20203, "intervention_name": "Lithium or Valproate with Aripiprazole", "condition_name": "Pulmonary Emphysema", "molecular_type": null, "therapeutic_area": "respiratory"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0460", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Peramivir\nDrug type: small_molecule\nCondition: Frontotemporal Dementia (FTD)\nTherapeutic area: neurology", "metadata": {"intervention_id": 1563, "condition_id": 10522, "intervention_name": "Peramivir", "condition_name": "Frontotemporal Dementia (FTD)", "molecular_type": "small_molecule", "therapeutic_area": "neurology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0461", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Canagliflozin 100 mg\nCondition: Colitis Ulcerative Exacerbation\nTherapeutic area: autoimmune", "metadata": {"intervention_id": 3298, "condition_id": 26683, "intervention_name": "Canagliflozin 100 mg", "condition_name": "Colitis Ulcerative Exacerbation", "molecular_type": null, "therapeutic_area": "autoimmune"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0462", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Atorvastatin 80mg\nDrug type: small_molecule\nCondition: Non-muscle Invasive Bladder Cancer\nTherapeutic area: oncology", "metadata": {"intervention_id": 3619, "condition_id": 5500, "intervention_name": "Atorvastatin 80mg", "condition_name": "Non-muscle Invasive Bladder Cancer", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0463", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Folinic acid\nDrug type: small_molecule\nCondition: Pleural Carcinomatosis\nTherapeutic area: oncology", "metadata": {"intervention_id": 1954, "condition_id": 21136, "intervention_name": "Folinic acid", "condition_name": "Pleural Carcinomatosis", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0464", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Thiotepa\nDrug type: small_molecule\nCondition: Larynx Cancer\nTherapeutic area: oncology", "metadata": {"intervention_id": 1071, "condition_id": 13001, "intervention_name": "Thiotepa", "condition_name": "Larynx Cancer", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0465", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Cabozantinib S-malate\nDrug type: small_molecule\nCondition: Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted\nTherapeutic area: oncology", "metadata": {"intervention_id": 13087, "condition_id": 39768, "intervention_name": "Cabozantinib S-malate", "condition_name": "Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0466", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: 5-fluorouracil\nDrug type: small_molecule\nCondition: Lung Cancer, Nonsmall Cell, Recurrent\nTherapeutic area: oncology", "metadata": {"intervention_id": 29, "condition_id": 37340, "intervention_name": "5-fluorouracil", "condition_name": "Lung Cancer, Nonsmall Cell, Recurrent", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0467", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: palifermin\nDrug type: peptide\nCondition: Tumor Bleeding\nTherapeutic area: oncology", "metadata": {"intervention_id": 4078, "condition_id": 6584, "intervention_name": "palifermin", "condition_name": "Tumor Bleeding", "molecular_type": "peptide", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0468", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Lopinavir/Ritonavir\nDrug type: small_molecule\nCondition: Small Fibre Neuropathy\nTherapeutic area: neurology", "metadata": {"intervention_id": 1482, "condition_id": 43995, "intervention_name": "Lopinavir/Ritonavir", "condition_name": "Small Fibre Neuropathy", "molecular_type": "small_molecule", "therapeutic_area": "neurology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0469", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: treprostinil sodium\nDrug type: small_molecule\nCondition: Recurrent Solid Tumors\nTherapeutic area: oncology", "metadata": {"intervention_id": 2408, "condition_id": 4429, "intervention_name": "treprostinil sodium", "condition_name": "Recurrent Solid Tumors", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0470", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Peficitinib\nDrug type: small_molecule\nCondition: Pancreatogenous Diabetes\nTherapeutic area: metabolic", "metadata": {"intervention_id": 5184, "condition_id": 46320, "intervention_name": "Peficitinib", "condition_name": "Pancreatogenous Diabetes", "molecular_type": "small_molecule", "therapeutic_area": "metabolic"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0471", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Evobrutinib\nDrug type: small_molecule\nCondition: HIV Pre-exposure Prophylaxis\nTherapeutic area: infectious", "metadata": {"intervention_id": 1733, "condition_id": 1807, "intervention_name": "Evobrutinib", "condition_name": "HIV Pre-exposure Prophylaxis", "molecular_type": "small_molecule", "therapeutic_area": "infectious"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0472", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: glatiramer acetate\nCondition: Malaria Prevention\nTherapeutic area: infectious", "metadata": {"intervention_id": 602, "condition_id": 46299, "intervention_name": "glatiramer acetate", "condition_name": "Malaria Prevention", "molecular_type": null, "therapeutic_area": "infectious"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0473", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: bicalutamide\nDrug type: small_molecule\nCondition: Pediatric Hypertension\nTherapeutic area: cardiology", "metadata": {"intervention_id": 265, "condition_id": 810, "intervention_name": "bicalutamide", "condition_name": "Pediatric Hypertension", "molecular_type": "small_molecule", "therapeutic_area": "cardiology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0474", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Lisinopril\nDrug type: small_molecule\nCondition: ISM\nTherapeutic area: other", "metadata": {"intervention_id": 3961, "condition_id": 54159, "intervention_name": "Lisinopril", "condition_name": "ISM", "molecular_type": "small_molecule", "therapeutic_area": "other"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0475", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Azilsartan medoxomil\nDrug type: small_molecule\nCondition: Lung Adenocarcinoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 6250, "condition_id": 1614, "intervention_name": "Azilsartan medoxomil", "condition_name": "Lung Adenocarcinoma", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0476", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Methotrexate (MTX)\nDrug type: small_molecule\nCondition: Pre-diabetes\nTherapeutic area: metabolic", "metadata": {"intervention_id": 6213, "condition_id": 3663, "intervention_name": "Methotrexate (MTX)", "condition_name": "Pre-diabetes", "molecular_type": "small_molecule", "therapeutic_area": "metabolic"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0477", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Panitumumab\nDrug type: monoclonal_antibody\nCondition: Durvalumab + Tremelimumab Combination Treatment, Pulmonary Sarcomatoid Carcinoma, NSCLC\nTherapeutic area: oncology", "metadata": {"intervention_id": 374, "condition_id": 31316, "intervention_name": "Panitumumab", "condition_name": "Durvalumab + Tremelimumab Combination Treatment, Pulmonary Sarcomatoid Carcinoma, NSCLC", "molecular_type": "monoclonal_antibody", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0478", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Total Body Irradiation (TBI)\nCondition: Primary Cutaneous Acral CD8-Positive T-Cell Lymphoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 6705, "condition_id": 22777, "intervention_name": "Total Body Irradiation (TBI)", "condition_name": "Primary Cutaneous Acral CD8-Positive T-Cell Lymphoma", "molecular_type": null, "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0479", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Gemcitabine\nDrug type: small_molecule\nCondition: Arrhythmia, Droperidol\nTherapeutic area: cardiology", "metadata": {"intervention_id": 27, "condition_id": 53295, "intervention_name": "Gemcitabine", "condition_name": "Arrhythmia, Droperidol", "molecular_type": "small_molecule", "therapeutic_area": "cardiology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0480", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Interleukin-2\nDrug type: peptide\nCondition: Kidney Injury Following Open-Chest Cardiac Surgery\nTherapeutic area: cardiology", "metadata": {"intervention_id": 219, "condition_id": 47037, "intervention_name": "Interleukin-2", "condition_name": "Kidney Injury Following Open-Chest Cardiac Surgery", "molecular_type": "peptide", "therapeutic_area": "cardiology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0481", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Pentamidine\nDrug type: small_molecule\nCondition: Coronary Artery Bypass Graft\nTherapeutic area: cardiology", "metadata": {"intervention_id": 274, "condition_id": 2353, "intervention_name": "Pentamidine", "condition_name": "Coronary Artery Bypass Graft", "molecular_type": "small_molecule", "therapeutic_area": "cardiology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0482", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: fludarabine phosphate\nDrug type: small_molecule\nCondition: Adult Oligodendroglioma\nTherapeutic area: oncology", "metadata": {"intervention_id": 743, "condition_id": 3555, "intervention_name": "fludarabine phosphate", "condition_name": "Adult Oligodendroglioma", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0483", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Palbociclib\nDrug type: small_molecule\nCondition: Fallopian Tube Mucinous Adenocarcinoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 3198, "condition_id": 15954, "intervention_name": "Palbociclib", "condition_name": "Fallopian Tube Mucinous Adenocarcinoma", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0484", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: escitalopram\nDrug type: small_molecule\nCondition: Over Active Bladder\nTherapeutic area: other", "metadata": {"intervention_id": 1252, "condition_id": 55570, "intervention_name": "escitalopram", "condition_name": "Over Active Bladder", "molecular_type": "small_molecule", "therapeutic_area": "other"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0485", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Ixazomib\nDrug type: small_molecule\nCondition: Stage IIIA Anal Cancer AJCC v8\nTherapeutic area: oncology", "metadata": {"intervention_id": 8723, "condition_id": 49833, "intervention_name": "Ixazomib", "condition_name": "Stage IIIA Anal Cancer AJCC v8", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0486", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Maraviroc 300 mg\nCondition: Placental Malaria Infection\nTherapeutic area: infectious", "metadata": {"intervention_id": 6917, "condition_id": 46521, "intervention_name": "Maraviroc 300 mg", "condition_name": "Placental Malaria Infection", "molecular_type": null, "therapeutic_area": "infectious"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0487", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Epinephrine\nDrug type: small_molecule\nCondition: Close Contact Transmission\nTherapeutic area: other", "metadata": {"intervention_id": 463, "condition_id": 14501, "intervention_name": "Epinephrine", "condition_name": "Close Contact Transmission", "molecular_type": "small_molecule", "therapeutic_area": "other"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0488", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Emtricitabine\nDrug type: small_molecule\nCondition: Parkinson's Disease With End of Dose Wearing Off\nTherapeutic area: neurology", "metadata": {"intervention_id": 1483, "condition_id": 43287, "intervention_name": "Emtricitabine", "condition_name": "Parkinson's Disease With End of Dose Wearing Off", "molecular_type": "small_molecule", "therapeutic_area": "neurology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0489", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Emtricitabine (FTC)\nDrug type: small_molecule\nCondition: Migraine in Adults\nTherapeutic area: neurology", "metadata": {"intervention_id": 1013, "condition_id": 53653, "intervention_name": "Emtricitabine (FTC)", "condition_name": "Migraine in Adults", "molecular_type": "small_molecule", "therapeutic_area": "neurology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0490", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Prednisolone\nDrug type: small_molecule\nCondition: Lymphoproliferative Malignancies\nTherapeutic area: other", "metadata": {"intervention_id": 771, "condition_id": 24801, "intervention_name": "Prednisolone", "condition_name": "Lymphoproliferative Malignancies", "molecular_type": "small_molecule", "therapeutic_area": "other"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0491", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Fluticasone\nDrug type: small_molecule\nCondition: Oxytocin, Lorazepam, Anti-Anxiety Agents, Physiological Effects of Drugs\nTherapeutic area: psychiatry", "metadata": {"intervention_id": 4943, "condition_id": 38474, "intervention_name": "Fluticasone", "condition_name": "Oxytocin, Lorazepam, Anti-Anxiety Agents, Physiological Effects of Drugs", "molecular_type": "small_molecule", "therapeutic_area": "psychiatry"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0492", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Midazolam\nDrug type: small_molecule\nCondition: Thalassemia Alpha\nTherapeutic area: other", "metadata": {"intervention_id": 47, "condition_id": 43825, "intervention_name": "Midazolam", "condition_name": "Thalassemia Alpha", "molecular_type": "small_molecule", "therapeutic_area": "other"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0493", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Diphenydramine\nDrug type: small_molecule\nCondition: Post-Acute COVID19 Syndrome\nTherapeutic area: infectious", "metadata": {"intervention_id": 6949, "condition_id": 21309, "intervention_name": "Diphenydramine", "condition_name": "Post-Acute COVID19 Syndrome", "molecular_type": "small_molecule", "therapeutic_area": "infectious"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0494", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: zoledronic acid\nDrug type: small_molecule\nCondition: Non-small-cell Lung Cancer With Somatic EGFR Mutations\nTherapeutic area: oncology", "metadata": {"intervention_id": 1459, "condition_id": 27873, "intervention_name": "zoledronic acid", "condition_name": "Non-small-cell Lung Cancer With Somatic EGFR Mutations", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0495", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Lapine T-Lymphocyte Immune Globulin\nCondition: Bone Metastatic Prostate Cancer\nTherapeutic area: oncology", "metadata": {"intervention_id": 1069, "condition_id": 47105, "intervention_name": "Lapine T-Lymphocyte Immune Globulin", "condition_name": "Bone Metastatic Prostate Cancer", "molecular_type": null, "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0496", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: ferric carboxymaltose\nDrug type: unknown\nCondition: Learning\nTherapeutic area: other", "metadata": {"intervention_id": 446, "condition_id": 6243, "intervention_name": "ferric carboxymaltose", "condition_name": "Learning", "molecular_type": "unknown", "therapeutic_area": "other"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0497", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Oxytocin\nDrug type: peptide\nCondition: Vascular Aging\nTherapeutic area: other", "metadata": {"intervention_id": 1095, "condition_id": 36750, "intervention_name": "Oxytocin", "condition_name": "Vascular Aging", "molecular_type": "peptide", "therapeutic_area": "other"}, "untested_type": "trick", "split": "test"} | |
| {"question_id": "CTL4-0498", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Voglibose\nDrug type: small_molecule\nCondition: Dose Escalation: Relapsed/Refractory Solid Tumor Malignancies or Lymphoma\nTherapeutic area: oncology", "metadata": {"intervention_id": 2272, "condition_id": 21025, "intervention_name": "Voglibose", "condition_name": "Dose Escalation: Relapsed/Refractory Solid Tumor Malignancies or Lymphoma", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "obvious", "split": "test"} | |
| {"question_id": "CTL4-0499", "task": "CT-L4", "gold_answer": "untested", "gold_category": null, "difficulty": null, "temporal_group": null, "context_text": "Drug: Capecitabine\nDrug type: small_molecule\nCondition: Cancer, Ovarian Stromal\nTherapeutic area: oncology", "metadata": {"intervention_id": 679, "condition_id": 43570, "intervention_name": "Capecitabine", "condition_name": "Cancer, Ovarian Stromal", "molecular_type": "small_molecule", "therapeutic_area": "oncology"}, "untested_type": "trick", "split": "test"} | |